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The frequent complexity of chromosome changes in sol id 
tumours has been regularly emphasized ever since the beginning of 
cytogenetic studies in cancer. This thesis presents a simple 
method of chromosome preparation using a direct cell harvest. 
The method yields a high frequency of metaphases and good 
spreading of chromosome within metaphases, which is suitable for 
karyotyping of solid gynaecological tumours. Using this method, 
cytogenetic analysis was performed on 20 tumour specimens 
including 12 cases of cervical cancer, 4 uterine corpus cancer 
一.•，and 4 ovarian cancer. In cervical cancer, all were squamous cell 
carcinoma with different clinical stages (I-III). Three uterine 
corpus cancers were endometrioid carcinoma with stage 工一II and 
one is leiomyosarcoma with stage III. Four ovarian cancer were 
serous adenocarcinoma with stage III-V. All of these patients did 
not receive cytotoxic therapy prior to the initial karyologic 
assessment. 
Extensive and complex numerical and structural alterations 
were seen in nearly all specimens. Aneuploidy was observed in all 
patients and there was considerable variation in number in the 
chromosome, often ranging from diploidy to triploidy to 
tetraploidy. The chromosomes most frequently involved in 
structural abnormalities were 1, 2, 3, 4, 5 and 11; the least 
vi 
involved chromosomes were 7, 8, 13 and 17. Partial deletions of 
Iq, 8p and lip were each seen in different cases. Breakpoints 
tended to recur at several chromosomal band regions, some of 
which were near the known loci of certain protooncogenes. In 
order to clarify the role of these chromosomal aberrations, it 
should be the focus of future analysis using molecular genetic 
techniques. 
In order to evaluate the cytogenetic evolutionary patterns 
during the in vitro establishment of a permanent ovarian 
carcinoma cell line, cytogenetic follow-up was carried out on 
serial passages for more than 1 year of in vitro propagation. In 
vitro cytogenetic analysis of the human ovarian carcinoma cell 
line OCCl was performed at passages 6, 30, 50, 80 and 110. 
Hypertriploid cells were present in nearly all cell population. 
Total twelve marker chromosomes were observed in these five 
passages. Chromosomes 1, 7, and 9 were found to be frequently 
involved in translocations, deletions, and isochromosome. 
Chromosomal acquisition of two new markers was seen in the 80th 
and 110th passages. The findings in this study provide additional 
evidence of chromosomal evolution during the in vitro culture of 
an ovarian cancer cell line. 
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CHAPTER 1 INTRODUCTION 
^ � 
1 
The study of the chromosome pattern in a number of human 
tumour cells has been one of the most exciting areas in cancer 
research over the last 30 years. Major advances in our 
understanding of the clinical implication of chromosome 
abnormalities have occurred in the last 20 years with the 
development of new chromosome banding techniques (Rowley & 
Ultmann, 1983). These techniques allow the identification of each 
human chromosome and their parts as well. Thus the hypothesis 
put forward by Boveri (Boveri, 1914) at the turn of the century, 
namely, that an abnormal chromosome pattern was intimately 
associated with the malignant phenotype of the tumour cell, can 
now be evaluated with substantial hope of obtaining an answer. 
Although solid tumours are accounted for a major portion in 
human cancer morbidity and mortality than do hematological 
neoplasias, much less is known about the cytogenetic 
abnormalities that characterize them. This is due primarily to 
the technical difficulties facing cytogenetic studies in solid 
tumour (Sandberg, 1980; Yunis, 1981), such as the difficulty to 
separate alive tumour cells from their peripheral connective 
tissue. Only since the past years successful analyses of the 
more common human cancers have been possible in a small numbers 
of cancer (Heim & Mitelman, 1987a). In spite of these recent 
improvements, the cytogenetic study of sol id tumours still 
comprise only 15% of the 8,000 neoplasms so far studied with 
banding techniques; these remaining 85% of neoplasms are of bone 
2 
marrow and lymphatic malignancies (Heim & Mitelman, 1987a). Most 
cytogenetic investigations have been made on highly advanced 
solid tumours, often metastatic lesions or effusion material, In 
these analyses, many additional abnormalities acquired during the 
late stages of tumour progression have undoubtedly contributed to 
the frequently bizarre karyotypic complexity encountered. 
However, the chromosomal anomalies are also highly complex even 
when the analysis is performed on diagnostic biopsies (Heim & 
Mitelman, 1987a). 
Cervical cancer, uterine corpus cancer and ovarian cancer 
are common malignancies in the females, As human solid tumours 
present many technical difficulties for cytogenetic studies 
(Sandberg, 1980; Yunis, 1981), relatively few chromosome studies 
have been made on gynaecologic tumours with banding techniques. 
This project aims to study the chromosome abnormalities of some 
solid gynaecologic tumours, namely cervical, uterine corpus and 
ovarian malignancies. The findings will be evaluated in term of 
the role of these chromosomal changes in tumourigenesis. 
The objectives of this project in details are : 
1. To establish a satisfactory method for the chromosome 
preparation in cervical, uterine corpus and ovarian malignancies. 
2. To determine any unique chromosomal abnormalities in the 
cervical, uterine corpus and ovarian malignancies, by detailed 
3 
karyotypic analysis of these tumors using G-banding technique. 
3. To show the presence of evolution of karyotypic changes 
in prolonged passages of an ovarian cancer cell line growing in 
vitro, 
4 





In 1839 Schleiden and Schwann established the concept of 
cells as the fundamental living units. Hereditary transmission 
through the sperm and egg became known by 1860 (Quote from Connor 
& Ferguson-Smith, 1987). 
In 1865, Gregor Mendel, an Austrian monk, studied single 
clearly defined pairs of contrasting characters in the offspring 
of the garden pea and reached three main conclusions: 
一' 1) Inheritance is particulate - Inherited characteristics 
are determined by pairs of hereditary elements (now called 
genes). 
2) Each pair of genes segregates (Mendel's first law)- The 
two members of a single pair of genes (the alleles) pass to 
different gametes during reproduction (i.e. alleles setgregate). 
3) The gene pairs show independent assortment (Mendel's 
second law)- Members of different gene pairs assort to gametes 
independently of one another (i.e. non-alleles assort). 
Although Mendel presented and published his work in 1865 the 
significance of his discoveries was not recognized until the 
early 1900s when three plant breeders, de Vries, Correns, and 
Tschermak independently rediscovered his findings. (Quote from 
6 
Connor & Ferguson-Smith, 1987) 
Chromosomes 
Walther Flemming identified chromosomes within the nucleus in 
1877, and in 1903 Sutton and boveri independently indicated that 
the behaviour of chromosomes during the production of gametes 
paralleled the behaviour of Mendel‘s hereditary units (Quote from 
Connor & Ferguson-Smith, 1987). Thus the chromosomes were 
discovered to carry the genes. However, at that time, although 
the chromosomes were known to consist of protein and nucleic 
acid, it was not clear which component was the hereditary 
material. 
The chemical basis of inheritance was not elucidated until 
several decades later. In experiments involving genetic 
transformation of pneumococci (Griffith, 1928; Avery et al., 
1944), deoxyribonucleic acid (DNA) was shown to be the hereditary 
material of all living organisms except certain viruses. 
Subsequently, several types of ribonucleic acid (RNA) were shown 
to be required to translate the information inherent in the 
•i genes. 
The normal human chromosome number of 46 was established by 
Tjio and Levan in 1956 (Tjio and Levan, 1956) . Chromosomes are 
the vehicles of heredity. Their behaviour in cell division 
7 
provides the basis for the Mendelian laws of inheritance. In 
addition, their organization is important for the other major 
functions of DNA: transcription and replication. Chromosomes 
contain virtually all the DNA of the cell, the only exception 
being the tiny amount of DNA in the mitochondria. Mitochondria 
are derived wholly from the ovum, and thus the few mitochondrial 
genes show strictly maternal inheritance. Chromosomes, on the 
other hand, are derived equally from mother and father. Each ovum 
or sperm contains a complete set of 23 different chromosomes, the 
haploid number (n) , while the diploid fertilized egg and 
virtually every cell of the organism arising from it have two 
complete sets (2n = 46), namely, 22 pairs of autosomes and a 
一pair of sex chromosomes. The sex chromosomes are designated XY in 
the male and XX in the female. 
Chromosomes are composed by weight of DNA (39%) , RNA (3%), 
histone proteins (45%) and non-histone proteins (13%) .A 
chromosome structure model has three levels of organization. The 
first level is the nucleosome which is composed of DNA wrapped 
around an octomer of histones. The second order is the chromatin 
which is made up of nucleosomes bound around monomers of histone 
1. The third and higher orders of organization are the folding 
and coiling of the chromatin strand which results in 
condensation of metaphase chromosomes. 
Clinical cytogenetic analysis usually involves the study of 
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metaphaee chromosomes. Such chromosomes consist of two �sister 
chromatids‘ held together by a centromere. In a typical karyotype 
the metaphase chromosomes are arranged according to the 
International System for Human Cytogenetic Nomenclature (ISCN 
1985) in which the length, centromeric position and banding 
pattern are used as criteria for chromosome identification as 
shown in Figure 2.1.1. 
2.2 Chromosome and Human Disease 
By 1890 it was known that one human chromosome (known as the 
accessory chromosome) did not always have a partner, and in 1905 
Wilson and Stevens extended this observation by establishing the 
pattern of human sex chromosomes. At this time there were 
believed to be 48 chromosomes in each somatic cell. Tj io and 
Levan rejected this in 1956 when they showed the normal human 
chromosome number to be 46 (Tjio and Levan, 1956) . In 1959 the 
first chromosomal disease in man, trisomy 21, was discovered by 
Lejeune and colleagues (Lejeune et al. , 1959). By 1970 over 20 
different human chromosomal disorders were known. The development 
of chromosomal banding in 1970 increased the ability to resolve 
small chromosomal aberrations, and so by 1980 more than 50 
different chromosome abnormalities were known, in addition to 
9 
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many normal variants (Connor Sc Ferguson-Smith, 1987). 
Genetic disorders are usually classified into the 
following four general categories: single-gene disorders, 
chromosomal abnormalities, multifactorial disorders and genetic 
component of common diseases (Weatherall, 1985). 
A classification of diseases having a genetic background 
would thus be: 
The first group is single gene defects, conditions which can 
be traced through families and clearly defined as following a 
dominant, recessive or sex-linked pattern of inheritance, for 
—example, monogenic hypercholesterolaemia, Sickle—cell anaemia 
and muscular dystrophy. 
The second group is chromosome abnormalities, some of which 
can be related to specific clinical syndromes, for example, 
Down's syndrome or Mongolism (trisomy 21) and Edwards‘ syndrome 
(trisomy 18). 
The third group comprises of congenital malformations, at 
least some of which seem to have a strong genetic component； it 
is equally clear, however, that environmental factors play a 
major role in the pathogenesis of many disorders which come under 
this heading, for example, anencephaly, spina bifida and 
cardiac malformations. 
Finally, the last group is a group of common diseases in 
which genetic factors are thought to play a role, for example, 
11 
Schizophrenia, epilepsy and diabetes mellitus although the 
relative contribution of genetic and environment factors is still 
not clear (Weatherall, 1985). 
2.3 Chromosome and Tumour 
In 1890, David Von Hansemann first drew attention to the 
frequent occurrence of mitotic irregularities in malignant 
tissues (Von Hansemann, 1890). He associated them with the origin 
• 一 
and development of malignancy and further suggested that such 
nuclear abnormalities could be used as a criterion for diagnosing 
the malignant state. Such notions formed the basis of the 
mutation theory of cancer, presented in 1914 by Theodor Boveri in 
his famous book "Zur Frage der Entstehung Maligner Tumoren in 
which chromosomal aberrations were suggested as the cause of the 
change from normal to malignant growth (Boveri, 1914). This 
remained a theoretical idea that could not be put to the test at 
that time throughout the first half of the 20th century, because 
of the technical difficulties in chromosome preparation. During 
the same period, plant cytogenetics had made a spectacular 
progress, largely due to the application of rapid squash and 
smear methods, which had simplified chromosome studies in plants 
as well as in insects, and at the same time disclosed chromosome 
12 
structures more clearly and often more reliably than that with 
the previously used microtome technique (Rowley & Ultmann, 1983). 
It was not discovered, until around 1950 that a malignant 
mammalian material, ascites cells from experimental 
tumors, responded very favorably to the same rapid method, and 
this led to the sudden realization that mammalian chromosomes 
could be just as suitable for detailed analysis as the plant 
materials. At that time, cells in mammalian tissue culture were 
made available as a source of chromosomes. This was possible due 
to the application of pretreatment with colchicine and hypotonic 
salt solution. During the 1950s and 1960s detailed karyotypes 
were worked out in an increasing number of mammalian species, 
including man. Clear-cut correlations were also established 
between specific chromosome deviations, numerical as well as 
structural, and a number of constitutional malformation 
syndromes. During the early 1950s, the study of chromosomes in 
animal ascites tumours, supplemented with results from human 
malignant exudates, had laid a firm foundation for modern cancer 
cytogenetics. 
In 1960, however, cancer cytogenetics had a first spectacular 
success: Nowell and Hungerford reported the first consistent 
ft 
chromosome abnormality in a human cancer; they observed an 
unusually small G group chromosome in leukemic cells from 
patients with chronic myeloid leukemia <Nowell and Hungerford, 
I960). This chromosome, which appeared to have lost about one-
13 
half of its long arm, was named the Philadelphia or Phi 
chromosome in honor of its city of discovery. Whether it was 
translocated to another chromosome could not be answered at that 
time because it was impossible to identify each human chromosome 
precisely with the techniques then available (Rowley & Ultmann, 
1983). 
The introduction of chromosome banding techniques by 
Caspersson and coworkers in 1970 completely revolutionized 
cytogenetic analysis (Caspersson et al., 1970)• Each chromosome 
could now be precisely identified on the basis of its unique 
banding pattern. 
Cancer appears to result from a failure of the precisely 
regulated growth of cells. Uncontrolled growth results in 
neoplasia. The approach to the genetics of cancer is similar to 
that for other common diseases: some cancers may be caused by 
mutant genes, some by chromosomal aberrations, and some by major 
environment interactions. 
In the past decade there has seen a large number of 
publication on the chromosomes of human tumours. The main 
objective of many of these papers is to search for characteristic 
chromosomal changes that are specific for particular types of 
tumour. Some specific changes have been uncovered, but most of 
these findings are in hematopoietic tumours rather than in the 







































































































































































































































































































































































































































































































































studies on carcinoma continue to lag behind those on leukemiae 
(Sandberg et al., 1988). Among carcinomas, there are more 
reports on certain histologic types (such as adenocarcinomas) 
and fewer on others (notably squamous cell carcinomas, which are 
technically less favorable). A small number of chromosomes tend 
to be nonrandomly involved in structural change in carcinomas, 
and it seems that while some chromosomes such as 1 and 11 are 
involved in many carcinoma (Atkin, 1986; Horgas et al., 1988； 
Atkin & Baker, 1988; Whang-Peng et al,, 1986), others perhaps 
are uniquely associated with a particular type, such as 
chromosome 10 in carcinoma of the prostate and chromosome 18 in 
一 . p o l o r e c t a l carcinoma (Atkin & Baker, 1985; Lundgren et al., 1988; 
Muleris et ai•, 1987; Vogelstein et al., 1988). 
Technical problems have hindered cytogenetic analyses of 
solid tumours. Sufficient numbers of tumour cells for analyses 
are obtained only with difficulty, and this often requires 
multiple surgical biopsies from a large piece of tumour tissue. 
In only a few reports have consistent abnormalities been 
demonstrated either in similar tumours from different patients or 
from different sites of involvement within the same patient 
(Rowley & Ultmann, 1983). 
Compared with leukemias, the chromosome changes in solid 
tumours are often complex. Cytogenetics analysis has not yet 
provided the molecular geneticists with the information necessary 
16 
to identify the critical genes involved in the malignant process. 
The molecular mechanisms in the malignant transformation of cells 
of solid tumours might involve multiple steps, since these cells 
must escape several levels of different environmental controls 
and restrictions. Thus, it may be difficult to find common 
cytogenetic differences in such tumour cells. However, such 
nonrandom chromosomal alterations will be found, at least in some 
of the solid tumours, and will provide the basis for a rational 
molecular genetic approach to the pathogenesis of human solid 
tumours (Croce, 1986). 
一--S - •-
2.4 Chromosome in Gynaecologic Tumours 
2.4.1 Cervical Tumour 
Anatomy of cervix uteri 
The cervix uteri is the lower portion of the uterus, It is a 
tubular structure measuring approximately 4 cm in length and 
about 3 cm in diameter (Koss, 1979). The epithelium of the cervix 
is of two types. The ectocervix, protruding into the vagina, is 
lined by non-keratinized stratified squamous epithelium similar 
to that of the vagina. The stratified epithelium extends 
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approximately to the external os where it changes to tall 
columnar epithelium covering the endocervical canal (Novak & 
Woodruff, 1974). 
During sexual maturity, the stratified squamous mucosa of the 
normal adult woman undergoes cyclical changes in response to 
ovarian hormone stimulus. The stratified squamous epithelium can 
be distinguished into the basal, middle and superficial layers. 
The basal layer is the layer of epithelial regeneration, and is 
composed of one row of small elliptical cells. Cells in the 
middle layers gain more cytoplasm as they mature towards the 
surface while the nuclear size remains more or less the same. 
_.This. layer can be subdivided into the parabasal and intermediate 
layer. The parabasal layer consists of smaller cells adjacent to 
the basal layer, and the intermediate layer consists of larger 
cells next to the superficial layer (Koss, 1979). 
The squamocoluranar junction is the transition point where the 
epithelium changes from stratified squamous to columnar. Eversion 
of the distal endocervical epithelium onto the portio vaginalis 
often occurs when the cervix changes in shape such as in 
pregnancy. The exposure of the columnar epithelium to the acid 
environment of the vagina results in its replacement by 
metaplastic squamous epithelium and a new squamocolumnar junction 
is formed (Coleman & Evans, 1988) . The area involved in 
metaplastic change is termed the transformation zpne. This is the 




The early study of chromosomal aberration was on HeLa cell 
line in which chromosome number was found to be 71 to 90 (Hsu & 
Mooshead, 19 57) . Later on, more and more evidences were 
established (Bottomley et ai., 1969; Hu et al., 1984) and such 
chromosomal abnormalities were suggested to play an important 
role in diagnosing the malignant state of tumours. 
一， -At present, although there have been a number of cytogenetic 
studies on carcinoma of the cervix (Spriggs, 1974; Atkin, 1976; 
Sandberg, 1980), detailed analyses of many studies of these 
tumors using chromosome banding techniques are lacking. It has 
been shown that, in common with other forms of cancer, structural 
and numerical changes involving chromosome 1 are frequent (Atkin 
& Baker, 1979), but it is not known whether nonrandom changes 
involving other chromosomes also occur in cervical cancer. The 
paucity of data is no doubt largely attributable to the technical 
difficulties involved in the processing of solid tumour tissue 
(Atkin Sc Baker, 1982). Cervical carcinomas are characterized 
by structural anomalies of chromosome 1, Iq-, 5q-, 11, and 17p+, 
isochromosome 17q, and a translocation between chromosomes 11 and 
19. Anomalies of chromosomes 1, 3, 16, 19, and 20 have also been 
19 
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reported (Atkin & Baker, 1984). 
In general, the chromosomal picture in this tumour type has 
been extremely variable and complex, the modal chromosome number 
was in the triploid or tetraploid region in more than one-third 
of all tumours. Often, the technical quality was so low and the 
changes so massive that even the stemline chromosome number could 
not be determined (Heim & Mitelman, 1987a). 
2.4.2 Uterine corpus tumour 
一， 如a亡o/ny of corpus uteri 
The uterus is a pear-shaped organ lying in the midline 
enclosed between the two layers of the broad ligament. It is 
divided into two major parts, the body and the cervix, which are 
separated by the isthmus, a narrow portion corresponding roughly 
to the internal os. This organ varies in size and in the adult 
parous female measures approximately 8 cm in length, 6 cm in 
width, and 4 cm in thickness. The wall of the uterus consists of 
three layers: an inner endometrium, a middle myometrium, and an 
external peritoneal (serous) coat (Jones et al., 1988). 
The myometrium shows cyclic changes, but the most striking 
changes occur in pregnancy. The smooth muscle of the wall of the 
uterus is very thick and is arranged in bundles separated by 
-i 
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cellular connective tissue that contains vessels. The inner 
layers are dispersed in a sphincter-like manner around the 
intramural portions of the uterine tubes. The intermediate layer 
is thick and irregularly dispersed with many large venous 
channels, giving it a spongy texture. The outer layer consists of 
intermingled longitudinal and circular fibers. There is a serous 
coat external to the myometrium, except laterally in relation to 
the attachment of the broad ligament (Danforth et al., 1982). 
The endometrium, the mucosa of the corpus, is made up of a 
specialized connective tissue stroma containing numerous tubular 
glands that open into the uterine cavity. It undergoes cyclic 
^changes governed by the interplay of hormones of pituitary and 
ovarian origin that underlie the menstrual cycle and is 
profoundly modified in pregnancy (Danforth et al., 1982). The 
anatomy of cervix has been described in above section. 
Chromosomal changes 
The commonest of the primary tumours encountered in the 
uterine body is adenocarcinoma. Squamous carcinoma is rare but 
when it occurs it develops in a glandular epithelium which has 
undergone squamous metaplasia. Sarcomas occur much less 
frequently than adenocarcinomas and include leiomyosarcoma which 
can develop within the myometrium or within a leiomyofibroma and 
the rarer cases developing from endometrial stroma (Whitfield, 
21 
1986). 
Although endometrial adenocarcinoma is a very common form of 
gynaecological cancer there are few cytogenetic studies of these 
tumours (Noumoff et al., 1988). Trisomy or tetrasomy for Iq is 
common in this tumour type. The chromosome 1 aberrations comprise 
both numerical (mostly trisomy) and all kinds of structural 
rearrangement, including isochromosomes, deletions, duplications, 
and translocations of both the long and short arms, without 
obvious clustering of breakpoints to specific bands or regions 
(Atkin and Baker 1982, 1984; Fujita et al., 1985; Couturier et 
al., 1988a). 
- — ~ c-
The other chromosome imbalances trisomies 10, 2, 7 and 12； 
structural anomalies of chromosome 3, 5, 6, 7, 8, 10, 11, 12, 14, 
15, 16, 19, 20, 21, 22 and X have also been reported (Jenkyn and 
McCartney, 1986; Couturier et al. , 1988a; Milatovich et al., 
1990). 
Uterine sarcomas are rare neoplasms, 1% of all malignant 
tumours of the uterus (Norris and Zaloudek, 1982). There have 
been several reports of cytogenetic studies in uterine sarcoma. 
The chromosome involved in structural abnormalities are 1, 2, 3, 
4, 5, 6, 7, 8, 9, 10, 11, 13, 17 and X. The karyotypic picture in 
this tumour type is diverse, often with complex numerical and 
structural changes (Mark, 1976; Becher et al., 1984; Nilbert et 
al., 1990). 
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2.4.3 Ovarian Tumour 
Anatomy of ovary 
The ovaries are two ovoid bodies which constitute the genital 
glands of the female. Each ovary is attached to the posterior 
leaf of the broad ligament by a fold of peritoneum called the 
mesovarium, through which pass the ovarian vessels and nerves. In 
infancy and childhood the ovary is a tiny elongated structure 
with a smooth surface, situated near the pelvic brim, and packed 
with primary oocytes. After the menopause the ovary becomes 
smaller 
in size and shrivelled in appeairance, these changes are 
the results of atrophy of the medulla, and not of scarring 
following repeated ovulation as is sometimes stated. No follicles 
are found in old age (Danforth et al., 1982). During puberty the 
ovary enlarges, approximately 3.5 cm in length and 1.5-2.5 cm in 
thickness. On the section, the ovary is divisible into an outer 
cortex and a central portion or medulla. Primordial follicles are 
mostly found in the cortex, the medulla is more vascular and 
contains spiral vessels. Covering the cortex is the so-called 
germinal epithelium, made up of a single layer of cuboidal 
epithelium. Beneath the epithelium is the cortical stroma, which, 
just beneath the epithelium, shows a slightly condensed layer 
called the tunica albuginea. The stroma itself is made up of 
compactly placed spindle connective tissue cells, in which the 
23 
follicular elements and their derivatives are seen (Jones & Jones 
Jr., 1982). 
Histologic classification of ovarian tumours 
This classification is based primarily on the microscopic 
characteristics of the tumours and thus reflects the nature of 
morphologically identifiable cell types and patterns (Jones & 
Jones Jr., 1982) 
1. Common "epithelial" tumour (serous tumour； mucinous 
JL,umoiir； endometrioid tumour; clear cell tumour; Brenner tumour; 
mixed epithelial tumour; undifferentiated carcinoma). 
2. Gonadal stromal tumour (granulosa-thecal cell tumour; 
thecoma； Sertoli-Leydig cell tumour； gynandroblastoma; 
nonspecific gonadal stromal tumour). 
3. Lipid cell tumour. 
4. Germ cell tumour (dysgerminoma； endodermal sinus tumour; 
malignant teratoma; benign teratoma; struma ovarii; carcinoid; 
embryonal cell carcinoma; choriocarcinoma). 
5. Gonadoblastoma. 
6. Unclassified tumour. 
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7. Secondary of tumour. 
Chromosomal changes 
Multiple numerical and structural chromosome abnormalities 
occur in ovarian tumour. In 1979, Trent and Salmon using the agar 
colony system, reported a specific nonrandom chromosomal 
abnormality in their ovarian cancer patients, a deletion of the 
long arm of chromosome 6 (6q_), which previously not been 
associated with ovarian cancers (Trent and Salmon, 1980). The 
year later. Wake et al. (1980) reported the same marker plus an 
-a^ddiiional specific marker involving chromosome 14 in their study 
of papillary serous adenocarcinoma of the ovary. Their analysis 
indicated that the 6q- and 14q+ markers had arisen through the 
reciprocal translocation t(6;14)(q21;q24), which consequently 
appeared to be a primary change specifically associated with 
ovarian papillary serous adenocarcinomas. 
The frequent occurrence of various 6q and 14q abnormalities 
has subsequently been confirmed both in papillary serous 
adenocarcinomas and in other histopathologic ovarian carcinoma 
•i 
subtypes (Trent & Salmon, 1981; Atkin & Baker, 1981; Whang-Peng 
et al,, 1984； Panani & Ferti-Passantonopoulou, 1985). 
Chromosome 1 abnormalities also appear to be one of the most 
common cytogenetic change in ovarian cancers. The chromosome 1 
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aberrations include deletions, duplications, translocations, and 
inversions of both the short and the long arms as well as 
formation of a Iq isochromosome. The breakpoints have mostly been 
mapped to lq36 and the distal half of the long arm (Atkin, 1977; 
Van der Riet-Fox et al., 1979; Whang-Peng et al., 1984) . Other 
chromosomes involved in structural abnormalities were 2, 3, 4, 6, 
7, 9, 10, 11, 14, 15, 17 and 19 (Trent & Salmon, 1981; Kusyk et 
ai., 1982； Panani & Ferti-Passantonopoulou, 1985). 
Much of the cytogenetic information available for ovarian 
carcinoma is provided by the study of cell lines (Buick et al., 
1985; Smith et al., 1987; Sheer et al., 1987). These usually 
f er better quality metaphase spreads and banding, and 
demonstrate some characteristics of tumour progression. 
2.5 Methodology in cytogenetics 
The investigation of karyotype abnormalities in tumours 
depends on the ability to arrest dividing neoplastic cells in 
metaphase or late prophase, the ability to achieve acceptable 
spreading and fixation of the chromosomes, and finally the 
ability to stain the chromosomes properly prior to microscopic 
examination. To ensure that any abnormal ities detected are 
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representative of in vivo conditions, direct preparations and 
short-term cultures are usually preferred to investigation of 
long-term cultures or cell lines (Heim & Mitelman, 1987a). 
2.5.1 Material 
Technical difficulties prevented reliable visualization of 
mammalian chromosomes, under both normal and malignant 
conditions, throughout the entire first half of the 20th century. 
Around 1950 came the discovery that a mammalian material ascites 
tumours, in particular the Ehrlich ascites tumour of the mouse 
- 一 - « -
responded very favorably to the squash and smear methods (Hsu, 
1979).These techniques were rapidly tried in other tissues as 
well, and in general, mammalian chromosomes were found to be just 
as amenable to detailed analysis as the most suitable plant 
materials. 
In the early 1960s, Nowell and Hungerford‘s discovery of 
Philadelphia chromosome greatly stimulated interest in cancer 
cytogenetics, but for some unknown reasons it remained an 
exceptional finding (Nowell et al., I960). 
In order to measure chromosomes using f low systems, a 
reliable source of growing cells from which chromosomes can be 
isolated is needed. Diploid fibroblast cultures or established 
cell lines have been used extensively, but it is now possible to 
27 
culture human lymphocytes and solid tumour cells to yield 
adequate mitotic indices for chromosome isolations. 
2.5.2 Method of chromosome preparation 
A large number of different methods, or rather method 
modifications, are used by research and clinical laboratories 
active in cancer cytogenetics. 
Cell division 
一 - r 
Chromosomes are normally visible only during cell division. 
Dividing cells are sufficiently common in some tissues to permit 
direct study. 
Cell division follows DNA synthesis and chromosome 
duplication. The time between the end of one cell division and 
the beginning of the next is one cell cycle. The two major events 
in the cell cycle are: the S phase, during which DNA synthesis 
and chromosome duplication occur, and mitosis or cell division. 
The time interval or gap between mitosis and the S phase is Gl, 
and the gap between the S phase and mitosis is called G2. 
Cytologically, the whole cell cycle is divided into interphase 
(Gl, S, G2) , and mitotic phase. The latter is subdivided into 
prophase, metaphase, anaphase and telophase. There is great 
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variation in the total cell cycle time, depending on the cell 
type and its stage of differentiation. Most of this variation in 
cycle length occurs in the G1 phase, and the average duration of 
different phases is shown Fig. 2.5.1. 
There are two types of cell division: meiosis, which occurs 
in germ cells, and mitosis, which occurs in somatic cells. This 
is true of meiotic divisions in the testis, and of mitotic 
divisions in bone marrow, epithelia and tumours. 
Cell culture methods have greatly extended the range of 
tissue and cell types from which dividing cells can be obtained. 
T|iese. include small lymphocytes, bone marrow, skin or other 
tissue fibroblasts, some tumour cells and amniotic fluid cells 
from pregnant women. It is, therefore, possible to carry out 
chromosome studies in an extremely wide range of clinical 
situations. 
Chromosomal study in solid tumours 
The main limitation for the cytogenetic analysis of solid 
Rumours lies in the difficulty to consistently obtain analyzable 
chromosomal preparation. The simplest procedure, called the 
"direct method", consists of incubating the disaggregated samples 
in culture medium containing colcemid for a few hours at 37°C in 
order to collect metaphases from the in vivo dividing cells. But 
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Figure 2.5.1 Cell cycle showing the average time taken by 
the different phases: Gl, after division the chromosome is single 
and does not synthesize DNA; S, the period of DNA synthesis； G2, 
the chromosome is now doubled； M, mitosis occupies a relatively 
small portion of the cell cycle. 
30 
this method gives a low yield of metaphases, and the morphology 
of chromosomes is often inadequate for banding (Sandberg, 1980). 
The cells released by the tumour specimen can also be 
incubated in a serum-supplemented culture medium for 1-3 days in 
order to recruit a larger number of the in vitro cycling cells 
(Trent e亡 ai•, 1986). This short-term suspension culture has been 
applied to various tumour samples but its reliability depends on 
the number of viable cells and their proliferative activity In 
vivo. 
In a much more sophisticated system, the tumour single cell 
suspension is embedded in a semisolid matrix of agar, agarose, or 
- 一 1 - « -
methylcellulose diluted with an enriched medium in Petri dishes, 
and the culture is harvested after prolonged incubation with 
colcemid after 3-14 days, when a sufficient number of growing 
clones is present. This selective culture method efficiently 
prevents fibroblast and other normal cell growth and allows the 
cytogenetic analysis of colonies of self-renewed tumour cells 
with a high mitotic index (Trent Sc Salmon, 1980). 
The most efficient and versatile method is to harvest mitotic 
cells after a monolayer short-term culture, which gives a 
satisfactory number of metaphases suitable for banding, allows 
identification of the karyotyped cells by various techniques, and 
is convenient for subculturing, In recent years, more and more 
investigators perform the disaggregation of cancerous tissue with 
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collagenase I, II, and IV for short-term cell culture (Kusyk et 
ai. , 1979; Wake et a!., 1981) to yield a larger number of 
viable cells which are able to divide in short-term culture. This 
technique also markedly improves the quality of banding. 
Chromosome preparation 
In the 1950'9, hypotonic solution, which swells cells due to 
the influx of water was found by Dr. T.C. Hsu and Dr. Hughes 
(Quote from Hack and Lawce, 1980) . Colcemid, which had been used 
extensively on plant mat eir ia 1 , was found to woirk well on 
mammalian cells to collect larger numbers of cells in metaphases. 
It also disrupts the spindle apparatus, which cause the 
chromosomes to string together and bend at the centromere. Using 
both colcemid and hypotonic solution, progress was made, and the 
diploid number of man was finally confirmed to be 46. The 
preparation of chromosome slides for light microscopy normally 
follows the procedure suggested by Hungerford (1965), which 
involves exposure of a cell population to colcemid. The exposed 
cell population is then treated with a hypotonic solution of KCl 
a/id subsequently fixed with a mixture of methanol and acetic 
acid. 
During mitosis, one of the changes that takes place in the 
cell is the disintegration of the nuclear membrane. The 
chromosomes are then held together by the cytoplasmic membrane 
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and the spindle apparatus. The first step of the harvest, the 
addition of the mitotic inhibitor, accumulates metaphases and 
prevents the formation of the spindle apparatus. At the beginning 
of the harvest procedure, all that holds the chromosomes together 
is the cytoplasmic membrane. During the second step of the 
harvest procedure, addition of the hypotonic solution, water 
rushes into the cell due to the concentration gradient caused by 
the less than physiological concentration outside the cell. The 
cytoplasmic membrane stretches as the cell swells, and the cell 
resembles a water balloon with chromosomes suspended inside. As 
long as this cell is in a fluid, it can retain its spherical 
-shape. In the third step of the harvest procedure, addition of 
the fixative , the cell is preserved in its swollen shape. 
Chromosome banding 
Essential to cytogenetic investigation is the banding of 
chromosomes, which allows their individual identification. The 
methods first developed used quinacrine mustard or quinacrine 
dehydrochloride to create transverse, fluorescing bands of 
if 
variable brightness. The procedure is called Q-staining and the 
resulting bands Q-bands. Other techniques resulting in an 
essentially identical banding pattern use the Giemsa-dye mixture, 
hence G-staining methods and G-band pattern, reverse or R-banding 
in which the bands stain in the opposite fashion from that seen 
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with G-banding. In contrast to the Q_,G- and R-bands, which are 
distributed along the entire length of the chromosome, some 
techniques stain only specific chromosomal structures or areas. 
These include methods to visualize the constitutive 
heterochromatin C-banding, the telomeric regions T-banding, and 
the nucleolus origins in the satellite stalks nucleolar 
organizer regions (NOR-banding) (Heim & Mitelman, 1987a). 
2.5.3 Karyotype analysis 
一 1 Somatic cells contain 46 chromosomes which are in the diploid 
(2n) number. Mature gametes have 23 or the haploid (n) number. A 
chromosome number which is an exact multiple of the haploid 
number and exceeds the diploid number is called polyploidy, and 
one which is not an exact multiple is called aneuploidy (Connor 
et al., 1987). In both man and laboratory animals the karyotypic 
abnormalities seemed to be of two kinds: nonrandom changes 
preferentially involving specific chromosomes, often as 
characteristic numerical or structural aberrations, and a 
frequently more massive random or background variation affecting 
all chromosomes equally. To differentiate between the two groups 
was exceedingly difficult (Heim & Mitelman, 1987a). 
Cytogenetic analysis provides a most useful and widely used 
tool for the identification of genotype changes and is the only 
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approach that can distinguish between primary and secondary 
changes. In addition, this analysis can provide clues to 
distinguish between dominant and recessive mechanisms of 
neoplastic transformation. In the spectrum of possible genotype 
changes, cytogenetic analysis can detect those changes that 
affect regions greater than about 3000 to 5000 kb (Sandberg et 
al. , 1988). If the change affects less than this amount, 
cytogenetic analysis will fail to detect it. 
Visible cytogenetic changes in tumors can be divided into two 
broad categories and several subcategories. Numerical changes, 
which consist of additions or losses of whole chromosomes, will 
E^sult in either minor amplification or loss of heterozygosity 
for complete chromosomal sets of genes. Structural abnormalities 
include translocations, inversions, deletions, insertions, 
amplifications, isochromosome , centric fragment, and ring 
chromosome. These changes can alter specific genes that are 
located at the breakpoints (Sandberg, 1980). 
Chromosomes are numbered according to their size and 
centromeric position. The centromere divides a chromosome into a 
short arm (abbreviated p) and a long arm (abbreviated q) . Based 
•i 
upon the position of the centromere, one can classify a 
chromosome as metacentric (p and q equal in length), 
submetacentric (q slightly greater than p) , acrocentric (q much 
greater than p, the centromere being nearly terminal), or 
telocentric (the centromere being terminal) (Simpson et ai., 
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1982). 
Chromosomal images cut from a photograph of the metaphase 
spread are arranged in seven groups, A to G, according to size as 
shown in Table 2.5.1. Within each group, chromosomes are arranged 
by position of the centromere and numbered (Nora Sc Fraser, 1989). 
In Figure 2.5.2 chromosomes from a normal human female are 
shown as they appear in metaphase and as they are displayed in a 
karyotype for study. The chromosomes have been individually cut 
of the photomicrograph and arranged on the basis of size and 
position of centromere. This convention, except for the banding 
pattern, was established at a meeting of human cytogeneticists in 
Denver in 1960 and is thus known as the Denver classification. At 
a similar meeting in London in 1963, it was agreed to use letter 
designations for the various groups as shown in Table 2.5.1. 
Further modifications have since been added at conferences in 
Chicago and Paris. A detailed supplement has been published 
by a standing committee installed by the Paris Conference <1985). 
Any numerical or structural anomaly is noted by using 
nomenclature developed by the Committee of Human Cytogenetic 
tlomenclature. 
Table 2.5.2 lists some symbols used to designate parts of 
chromosomes and certain rearrangements. Chromosomes are 
identified by distinctive landmarks. The areas between adjacent 
landmarks are called regions. 
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Table 2.5.1 Description of Human Mitotic Chromosomes Adapted 
from the Denver �1960) and London (1963) Conferences 
Group 1-3 (A) Large chromosomes with approximately 
median centromeres (metacentric, 
submetacentric) readily distinguished 
from each other by size and centromere 
position. In No. 1 a secondary 
constriction may be observed in the 
proximal region of the long arm. 
Group 4 - 5 (B) Large chromosomes with submetacentric 
centromeres. Chromosome 4 is slightly 
longer. 
Group 6-12 and the X Medium-sized submetacentric chromosomes 
chromosome (C) 
Chromosomes 6, 7, 8, 11, and X are 
comparatively more metacentric than 
9, 10, and 12. The X chromosome most 
resembles No.6. 
Group 13-15 (D) Medium-sized submetacentric chromosomes 
with satellites on the short arms. 
Qroup 16-18 (E) Rather short submetacentric chromosomes. 
No.16 is comparatively more metacentric 
and may have a secondary constriction 
in the proximal part of the long arm. 
Group 19-20 (F) Short metacentric chromosomes. 
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Group 21-22 and the Y Very short acrocentric chromosomes, 
chromosome (G) 
Nos. 21 and 22 may have satellites. 
- • 一 — 
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Figure 2.5.2 Normal human female karyotype 
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h secondary constriction 
i isochromosome 
ins insertion 
- .-a — 
inv inversion 
inv ins inverted insertion 
mar marker chromosome 
mat maternal origin 
pat paternal origin 
r ring chromosome 
rep reciprocal translocation 
rec recombinant chromosome 
rob Robertsonian translocation {centric fusion) 
s satellite 
t translocation 
tan tandem translocation 
ter terminal or end (pter = end of short arm 
qter = end of long arm) 
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tri tricentric 
: break (no reunion, as in a terminal deletion) 
:： break and join 
from-to 
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2.6 Problems of cytogenetic analysis in solid tumour 
Culture 
A significant percentage of solid tumors has a very low 
mitotic index, which may account for the failure in the culture 
tumour cells in some cases or may lead to overgrowth by normal 
diploid cells. Additionally, the dominant cells following 
prolonged culture may not necessarily represent the major clone 
in the tumour in vivo and generally tend to have a large number 
of chromosomes with an array of numerical and morphological 
chromosomal anomalies (Sandberg et al., 1988). 
The morphology of the chromosomes in solid tumours is more 
often fuzzy and less than optimal for detailed analysis than the 
cell morphology encountered in leukemias. This aspect of solid 
tumours, however, has largely been overcome by recently 
introduced innovations in tissue culture and cytogenetic 
methodologies (Kusyk et al., 1979; Wake et al., 1981; Gibas 
et al., 1984; Limon et al., 1986). These innovations include a 
number of step, the most crucial of which consist of prolonged 
exposure of the cells to collagenase, the use of methotrexate for 
clearer banding of chromosomes and, most importantly, frequent 
examination of the cells in culture for their mitotic activity in 
order to establish the peak of such activity. This means that 
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usually cytogenetic examination of solid tumours requires not 
only more time and effort than do leukemic cells but also 
expertise in tissue culture techniques and knowledge of cell 
morphology and behaviour in vitro (Sandberg et al., 1988). 
Despite these methodologic developments, the standard 
monolayer culture method using a plastic substrate and a serum-
supplemented medium has two major limitations: the inconsistent 
adhesion and spreading of malignant cells (Alitalo & Vaheri, 
1982), and the frequent overgrowth of cultures by stromal 
fibroblasts that adhere more readily to plastic and are 
stimulated by high concentration of serum (Cailleau, 1975; Dendy, 
3:976)A recent evaluation of the methodologic aspects of human 
solid tumour cytogenetics has revealed that these problems have 
not yet been resolved (Trent et al., 1986). 
Solid tumours are frequently infected (particularly those of 
the gastrointestinal tract, lung, and cervix), so that upon 
culture, even for a brief period of time, the infecting organisms 
destroy the tumour material or make cytogenetic examination 
impossible. In addition, for optimal chromosome results, viable 
tumour tissue is necessary; however, some tumours are associated 
with necrosis and may not yield sufficient metaphases for 
analysis (Sandberg et al., 1988). 
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Analysis 
It is obvious that no available method can ensure success in 
each instance, because the results depend above all on the 
intrinsic characteristics of the tumour samples, i.e., the number 
of viable cells, the size of the necrotic areas and fibrous 
stroma, and the in vitro growth and differentiation rate of the 
tumour cells in a given culture system (Teyssier, 1989). 
The main restriction for the cytogenetic analysis of solid 
tumours lies in the difficulty to consistently obtain analyzable 
chromosomal preparations. This difficulty is due to the low ±n 
vivo mitotic activity of most tumours, the frequent low yield of 
viable cells, the not infrequent overt or cryptic infection of 
samples, and the extensive infiltration of tumour tissue by 
normal stromal cells such as fibroblasts (Teyssier,1989). 
Results of ±n vivo and In vitro experimental carcinogenesis 
are also consistent with the implication of karyotypic alteration 
in both cell transformation and tumour progression (Isaacs et 
al,, 1982 ； Cram et al., 1983; Popescu et al., 1986; Aldaz et 
al., 1987). Nevertheless, how and when these chromosomal changes 
occur in the multistep cancer process still remains a mystery, 
and the significance of karyotypic alterations in tumorigenesis 
appears to be complex. Different chromosome changes have been 
observed in neoplastic cells, and these often occur in 
combination. This leads to great difficulty in trying to identify 
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precisely the unique abnormalities in a particular cancer (Devita 
et al,, 1989). 
Although chromosome studies on carcinomas are still at an 
early stage, it is possible to speculate on the significance of 
the differences between these common cancers of middle and old 
age and the various forms of leukemia, lymphoma, and soft tissue 
cancers that are less common and occur equally or predominantly 
at an earlier age. The later onset of carcinomas may result from 
evolutionary selection that can operate on these common cancers, 
while it is too feeble to effect in the onset of sarcomas whose 
predisposing gene combinations are much less common (Huxley, 
1"958)-; Thus there may be fundamental differences in the pathways 
along which carcinomas develop as compared with other forms of 
cancer, perhaps including the need for carcinomas to undergo a 
greater number of successive genetic changes. However, 
clarification of this question must await more molecular and 
chromosomal data. As regards the latter, short-term culture 
techniques need to be developed that employ tumour-specific 
mitogens； further development of the new techniques of interphase 
cytogenetics whereby specific chromosomal regions can be 
identified by in situ hybridization with suitable probes in 
interphase tumour cells is awaited with interest (Devilee et al., 
1988). The ultimate goal of the molecular and chromosomal study 
of cancer cells is the identification of the genes involved in 
neoplastic transformation. Recent evidence that introduction of 
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the retinoblastoma gene, a tumour-suppressor gene, into 
retinoblastoma cells (that lack this gene) in culture results in 
the loss of their malignant phenotype raises the hope that, 
besides being of fundamental interest (Huang et al., 1988), 




CHAPTER 3 MATERIALS AND METHODS 
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3.1 Chemicals and Solutions 
Phosphate buffered saline (PH 7,4). 8.0 g NaCl, 0.2 g KCl, 
1.25 g Na2HPO^ and 0.2 g KH2PO4 were diluted to 1,000 
ml distilled water. 
Phosphate buffered saline (PH 6.8), 1 buffered tablet (0.5 g) 
was diluted to 1,000 ml distilled water (GIBCO 
Laboratories, USA). 
Washing solution. Phosphate buffered saline (PH 7.4) was 
- 一 � -
supplemented with 200 U/ml penicillin and 200 jug/ml 
streptomycin. 
Culture medium, RPMI-1640 (GIBCO Laboratories, USA) was 
supplemented with 15% fetal bovine serum (Flow 
Laboratories, UK), 3 mg/ml L-glutamine (Flow 
Laboratories, UK), 100 U/ml penicillin, 100 jug/ml 
streptomycin. The solution was sterilized by-
filtration and stored at 4 The solution can be used 
^ up to 2 months. 
Collagenase stock solution. Collagenase IV (Sigma Co., USA) 
was dissolved in culture medium (2,000 U/ml). The 
solution was sterilized by filtration and aliquoted into 
2 ml small tubes, which can be used up to 1 month. 
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Colcemid stock solution. 10 jug/ml of Colcemid (GIBCO 
Laboratories, USA) was dissolved in sterile distilled 
water. 
Hypotonic solution, 0.34% KCl solution (0.045 M) was used. 
Fixative solution. 3 parts methanol and 1 part glacial 
acetic acid were mixed. 
Trypsln-EDTA solution. 0.05% (w/v) trypsin and 0.02% 
EDTA were prepared in phosphate buffered saline (PH7.4) 
and stored frozen. 
Trypsin stock solution. 0.5% trypsin. 
Normal saline. 8.5 g NaCl was dissolved in 1,000 ml 
distilled water. 
Wright's stain stock solution. 0. 6 g Wright‘s stain powder 
was dissolved in 200 ml methanol and kept at room 
temperature for 7 days. The solution was then filtered 
through Whatmann No.1 filter paper and kept in the dark. 
— All general chemicals in above-mentioned solutions were 
purchased from Sigma Co., USA. 
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3.2 Chromosome preparation from solid gynaecologic tumours 
3.2.1 Solid tumour specimens 
Solid tumour specimens, in which chromosome preparation was 
successful, were obtained from 20 patients with gynaecologic 
malignancies, including 12 cases of cervical cancer, 4 uterine 
corpus cancer and 4 ovarian cancer, undergoing surgery or biopsy 
at the Department of Obstetrics and Gynaecology, The Chinese 
Urrivef'sity of Hong Kong, from June 1990 to August 1991. At 
the time of the cytogenetic analysis, none of the patients had 
received radiotherapy or chemotherapy. Clinical and pathological 
data of these tumours are summarized in Table 3.2.1-3. The 
clinical staging was performed according to the FIGO system 
(Kottmeier, 1979). The histological typing and grading were 
according to the WHO system (Serov & Scully, 1973). 
Excised pieces of tumour tissues obtained aseptically were 
immediately delivered to the laboratory in sterile empty glass 
bottles with stopper. The tissues were processed within 30 min 
after arrival in the laboratory. 
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Table 3.2.1 Clinical and pathological data from 12 cases of 
cervical cancer 
Case Age Clinical stage Pathological grading^ 
(yr) (FIGO) 
1 59 Illb P 
2 54 lb M 
3 61 lib P 
4 31 lb P 
5 28 lb P 
6 69 lb P 
r^ 65 iia P 
8 49 lib M 
9 56 Ila P 
10 60 Illb P 
11 65 Ilia M 
12 70 lb M 
a w, well; M, moderate; P, poor. All cases were squamous cell 
carcinomas. 
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Table 3.2.2 Clinical and pathologic data from 4 cases of uterine 
corpus cancer 
Case Age Clinical stage Histological type 
(yr) (FIGO) 
1 46 Ilia Leiomyosarcoma 
2 63 lb Endometrioid carcinoma^ 
3 59 lb Endometrioid carcinoma^ 
4 57 工la Endometrioid carcinoma^ 
a moderately differentiated. 
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Table 3.2.3 Clinical and pathological data from 4 cases of 
ovarian cancer 
Case Age Clinical stage Histological type 
(yr) (FIGO) 
1 30 IIIc Serous adenocarcinoma^ 
2 5 7 Illb Serous adenocarcinoma^ 
3 69 Illb Serous adenocarcinoma^ 
4 40 IV Serous adenocarcinoma^ 
^poorly differentiated, ^moderately differentiated. 
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3.2.2 Chromosome preparation 
The following two methods were used in the initial 
experiments for chromosome preparation from solid tumour tissues. 
Method 1 : Short-term enzymatic tissue disaggregation 
a. Tumour dissociation 
1. Wash specimen with washing solution (37° C) twice. 
2. Transfer the specimen into a sterile Petri dish, and 
remove fat, necrotic tissue and blood clots. 
3. Mince the tissue with scissors into small pieces of 
0.5-1 mm in diameter. 
4. Transfer the pieces into a 15 ml sterile conical 
tube, add 10 ml of washing solution (37° C) , and let 
stand for 5 min. 
5. Centrifuge the tube at 100 g for 5 min and remove 
the supernatant. 
6. Resuspend the resulting pellet containing small 
-f 
pieces of tissue in 5 ml of culture medium and 
2 
transfer the suspension to a sterile 25 cm culture 
flask. 
7. Add collagenase stock solution at a final 
concentration of 200 U/ml and incubate at 37 ° C in a 
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humidified 5% CO^ atmosphere for 4-16 h, depending on 
the degree of disaggregation of the tumour cells. 
8. Transfer the entire contents of the flask to a 
centrifuge tube. 
9. Disperse the specimen by passing through a pipette 
several times. 
10. Centrifuge the sample at 100 g for 5 min. 
11. Discard the supernatant and resuspend the cells and 
small pieces in 5 to 10 ml of culture medium, then, 
distribute the suspension in one or two culture 
flasks depending on the amount of the sample. 
—-s 
b. Culturing 
1. Incubate the flask at 37° C in 5% CO? atmosphere. 
2. Replenish with culture medium after the first 24 h 
of incubation. 
3. Renew the culture medium in flasks on alternate days. 
4. Examine the cultures daily using an inverted 
microscope. 
5. Harvest individually when the colonies are big 
enough and are actively proliferating. 
•t 
c. Harvesting and slidemaking 
1. Add Colcemid to the cultures at a final concentration 
of 0.02 A i g/ml and continue to incubate at 37° C for 
2-6 h. 
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2. Lightly scrape the cells attached to the bottom of 
flask using a sterile rubber policeman, and transfer 
the entire contents of the flask into a 
sterile centrifuge tube and centrifuge at 100 g for 
5 min. 
3. Discard the supernatant and suspend the cell pellet 
with 8 ml of hypotonic solution, and stand at 37°C 
for 30 min. 
4. Centrifuge the tube at 100 g for 5 min, discard the 
supernatant and fix the cells using fixative 
solution with three changes. 
5. Drop the cell suspension on clean and dry slides, 
• — 
and incubate the slides at 60°C overnight. 
d. G-banding and staining 
1. Place the slides in a cuvette with 0.04 ml of 0.5% 
trypsin in 50 ml of phosphate buffered saline (PH 
7.4) for 2-3 min, then wash slides with 0.85% NaCl 
solution and air-dry the slides. 
2. Stain the slides in Wright stain stock solution 
mixed with phosphate buffered saline (PH 6.8) (1:3 
^ v/v) for 4 min. 
This Method 1 of chromosome preparation was used in the first 
pilot study of 5 cases with cervical cancer. Recognizable 
metaphases were obtained in 3 cases, while in two case there were 
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only normal metaphases suggestive of fibroblast in origin. 
Method 2: Direct preparation 
a. Tumour dissociation 
1. Wash specimen with washing solution (37°C) twice. 
2. Transfer the specimen into a sterile Petri dish, and 
remove fat, necrotic tissue and blood clots. 
3. Mince the tissue with scissors. 
4. Suspend the specimen in 5 ml of culture medium, and 
force the suspension through a steel sieve (100 mesh). 
5. Centrifuge the filtered suspension at 100 g for 5 
min, and discard the supernatant. 
6. Add 5 ml of culture medium to the pellet, and 
transfer the suspension to a sterile Petri dish. 
b. Harvesting and slidemaking 
1. Add Colcemid to the Petri dish at a final 
concentration of 0.02 >ug/ml and incubate at 37 °C for 
2-6 h. 
2. Transfer the entire contents of the dish into a 
sterile centrifuge tube and centrifuge at 100 g for 5 
min. 
3. Discard the supernatant and resuspend the cell pellet 
with 8 ml of hypotonic solution, and stand at 37�C 
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for 30 min. 
4. Centrifuge the tube at 100 g for 5 min, discard the 
supernatant and fix the cells using fixative solution 
with three changes. 
5. Drop the cell suspension on clean, dry slides and 
incubate the slides at 60° C overnight. 
c. Banding and Staining 
As the same as previously described in Method 1. 
This Method 2 of chromosome preparation was used in the 
second pilot study of 5 cases with cervical cancer. Recognizable 
mefeapha-ses were only obtained in 2 cases, while no case was 
banded successfully. This is due to the fuzzy morphology of the 
chromosome, which makes banding impossible or less than optimal 
for detailed analysis. 
Method 3: An improved method of direct chromosome preparation 
a. Tumour dissociation 
^ 1. Wash specimen with washing solution (37° C) twice. 
2. Transfer the specimen into a sterile Petri dish, and 
remove fat, necrotic tissue and blood clots. 
3. Mince the tissue with scissors into small pieces of 
around 0.5 mm in diameter. 
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4. Suspend the tissue fragments in 5 ml of culture 
medium. 
b. Harvesting and slidemaking 
1. Add Colcemid solution at final concentration of 2 
wg/ml to the dish and incubate the dish containing 
tissue fragments at 37 °C in 5% CO? atmosphere for 30 
rain, 1.5 h, or 3 h. 
2. Transfer the entire contents of the dish to a 
sterile conical tube and centrifuge at 100 g for 5 
min. 
3. Discard the supernatant and resuspend the pellet in 8 
” ml of hypotonic solution, and incubate at 37° C in a 
water bath for 30 min. 
4. Add 0.5 ml of fixative solution into the tube for 
pre-fixative, and stand at room temperature for 5 
min. 
5. Centrifuge at 100 g for 5 min, and discard the 
supernatant. 
6. Add 1 ml of 60% glacial acetic acid into the tube, 
and stand at room temperature for 2 rain, then, add 2 
^ ml methanol and mix thoroughly. 
7. Centrifuge at 100 g for 5 min, and discard the 
supernatant, then, add 8 ml of fixative solution into 
the tube. 
8. Leave the tube at 4� C for 2 h. 
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9. Force the tissue fragments suspension through a steel 
sieve (100 mesh) and collect the cell suspension into 
a sterile conical tube. 
10. Centrifuge at 100 g for 5 min, discard the 
supernatant and wash the pellet twice with fixative 
solution. 
11. Resuspend the cells in 1-3 ml of fixative solution 
depending on the number of cells. 
12. drop the cells on clean and dry slides, and incubate 
the slides at 60°C overnight. 
c. Banding and staining 
-As the same as previously described in Method 1. 
After the initial experiments using Methods 1 and 2 of 
chromosome preparation with unsatisfactory results, the protocol 
was modified to use this Method 3 - an improved method of direct 
chromosome preparation. Using this method, 20 cases of 
gynaecological tumour obtained metaphases and produced successful 
banding. 
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3.3 Chromosome preparation from an established 
ovarian cancer cell line 
3.3.1 Origin of OCCl cell line 
An ovarian carcinoma cell line designated as OCCl, was 
established in the Gynaecologic Cancer Research Laboratory, 
Department of Obstetrics and Gynaecology, The Chinese University 
of Hong Kong (Wong et al., 1990). A sample of ascitic fluid was 
taken by abdominal paracentesis from a 47-year-old woman and 
sufejeated to primary culture on August 20, 1988. Histology of 
the ovarian cyst showed clear cell adenocarcinoma. The tumour was 
composed of papillary or glandular structures consisting of 
sheets of tumour cells with large pleomorphic nuclei and clear 
eosinophilic cytoplasm. 
3.3.2 Characteristics of OCCl cell line 
-Analysis of growth curve of the OCCl cell line showed that at 
the 10th and 40th passages, the population doubling times were 38 
and 36 hours, the plating efficiencies were 20 and 22%, and the 
saturation densities were 2.22 and 2.25 x 10 ^ cells / 35-mm-
diameter dish, respectively. Histological evaluation of 
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xenografts from OCCl cells in the 33th passage implanted and 
grown in nude (athymic) mice revealed a clear cell-like 
morphology, resemble that of the original tumour from which the 
OCCl cell line was derived. 
3.3.3 Maintaining of cell line 
The cells were grown in medium of RPMI-1640 (GIBCO 
Laboratories, USA) supplemented with 10% fetal bovine serum (Flow 
Laboratories, UK), 100 lU/ml penicillin, and 100 >ug/ml 
streptomycin (Sigma Co., USA) as monolayer. This cell line was 
subcultured for more than 130 passages. There was no change in 
culture medium or serum requirement throughout the passages. 
3.3.4 Chromosome preparation 
a. Cell culturing 
1. Inoculate 5 x 10^ cells in 5 ml of culture medium 
2 into a sterile culture flask (25 cm ). 
2. Incubate the flask with the cap loosely closed at 37° 
C in a humidified 5% CO] atmosphere. 
3. Daily check for the attachment and the growth of 
cells under an inverted microscope. 
4. Change the medium after 3 days of incubation, and 
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change it every 3-4 days thereafter until harvest. 
5. Prepare to undergo harvesting when the monolayer is 
80% confluent. 
6. Change the medium once again 24 h before harvest. 
b. Cell harvesting 
1. Add Colcemid at final concentration of 0.025 /ag/ml 
into the flask, and continue to incubate at 37°C for 
a period of 5 h. 
2. Discard the culture medium containing Colcemid 
(0.025 >ag/ml). 
3. Wash the monolayer of cells in the flask with 
phosphate buffered saline (PH 7.4) twice. 
4. Discard the phosphate buffered saline and add 0.5 ml 
of trypsin-EDTA solution and incubate the flask at 
37° C for 2-5 min until the cells completely detach 
from the bottom of flask. 
5. Add 9.5 ml of culture medium into the flask to 
neutralize the remaining trypsin . 
6. Transfer the trypsinized cultures to a 15 ml 
centrifuge tube. 
7. Centrifuge the tube at 175 g for 8 min. 
8. Discard the supernatant and add hypotonic solution 
(37°C) while vortexing. 
9. Incubate the tube at 37°C water bath for 30 min. 
10. Centrifuge the tube at 175 g for 8 min, and discard 
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the supernatant. 
11. Add 2 ml of freshly prepared fixative solution 
slowly while vortexing. 
12. Stand the tube at rome temperature for 2 rain, then 
add 4 ml more of fixative solution. 
13. Centrifuge the tube at 175 g for 8 min and refix the 
cell pellet with fixative solution. 
14. Repeat the step 13 for three times. 
15. Remain the cell in refrigerator at 4°C for 3-7 days 
before dropping slides. 
c. Slidemaking 
—-a - -
1. Hold dry slide at a downward angle and drop 2 
drops of cell suspension onto slide from a height of 
12 inches. 
2. Store slides in a 60° C oven at least overnight 
before banding can be attempted. 
d. G-banding 
1. Place the slides in a cuvette with 0.04 ml of 0.5% 
trypsin in 50 ml of phosphate buffered saline (PH 
< 7.4) for 2-4 min, then wash slides with 0.85% NaCl 
solution and air-dry the slides. 
2. Stain the slides in Wright stain stock solution 
mixed with phosphate buffered saline (PH 6.8) (1:3 
v/v) for 4 min. 
64 
3. Rinse the slides thoroughly with distilled water and 
air dry them. 
3.4 Karyotype analysis 
For karyotyping, the G-banded chromosomes in slide 
preparation were photographed, then cut from the paper prints and 
arranged. 
.一？ In—all of 20 cases with solid gynaecologic tumour, in which 
chromosome preparation was carried out using Improved Method of 
Direct Chromosome Preparation (Method 3) as described previously 
in Section 3.2, at least 50 metaphase spreads were counted and 10 
cells karyotyped. Karyotypes were analyzed according to the 
International System for Human Cytogenetic Nomenclature (ISCN 
1985). 
Five In vitro passages (P6, P30, P50, P80 and PllO) were 
cytogenetically analyzed on OCCl cell line. In each passage 
it 
chromosome counts were performed on 100 cells when suitable 
metaphase spreads were obtained. Karyotypes were further analyzed 
on 10 cells from each passage. Karyotypes were also analyzed 
according to ISCN (1985). 
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4.1 Cytogenetic features of gynaecologic solid tumour 
Successful banding analysis was obtained in 20 cases with 
gynaecologic solid malignant tumours which include 12 cervical 
cancers, 4 uterine corpus cancers and 4 ovarian cancers. 
Following the application of chromosome banding, a variety of 
complex structural changes of chromosome were identified. Changes 
that were found in more than two cells within each case are 
described in details as the followings. 
4.1.1 Cervical cancer 
Highly variable chromosome complements regarding numerical 
and/or structural abnormalities characterized all 12 cases with 
cervical squamous cell carcinoma as shown in Table 4.1.1. It 
appeared that the chromosomes most frequently associated with 
numerical and/or structural changes in these cases were 
chromosomes 1, 3, 5, 17 and 20, in which the abnormal frequency 
was or was more than 67%. Chromosome counts showed that one of 
the tumours was hypodiploid, seven were hyperdiploid, two were 
hypotriploid, one was hypertriploid, and one was hypotetraploid. 
Analysis of ten metaphases from each sample allowed 
establishment of the main cytogenetic features, as shown in Table 
4.1.2. The karyotypes of all cases were presented in Figures 
4.1.1-12. 
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Table 4.1.1 Frequency of numerical and/or structural 
abnormalities of chromosome in 12 cases of cervical cancer 
Chromosome Number of case with abnormalities (Percentage) 
number 
Numerical Structural Numerical and/or 
Structural 
1 8 (67%) 4 (33%) 9 (75%) 
2 7 (58%) 2 (17%) 7 (58%) 
3 10 (83%) 1 (8%) 10 (83%) 
4 7 (58%) 1 (8%) 7 (58%) 
5 8 (67%) 1 (8%) 8 (67%) 
6 5 (42%) 0 5 (42%) 
7 5 (42%) 1 (8%) 5 (42%) 
8 4 (33%) 0 4 (33%) 
9 5 (42%) 1 (8%) 5 (42%) 
10 — - 7 (58%) 0 7 (58%) 
11 3 (25%) 1 (8%) 4 (33%) 
12 3 (25%) 0 3 (25%) 
13 6 (50%) 0 6 (50%) 
14 5 (42%) 0 5 (42%) 
15 5 (42%) 0 5 (42%) 
16 7 (58%) 0 7 (58%) 
17 7 (58%) 1 (8%) 8 (67%) 
18 5 (42%) 0 5 (42%) 
19 6 (50%) 0 6 (50%) 
20 8 (67%) 0 8 (67%) 
21 5 (42%) 0 5 (42%) 
22 4 (33%) 0 4 (33%) 
X 3 (25%) 0 3 (25%) 
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Table 4.1.2 Cytogenetic features of cervical cancer 
Case Number of Modal number Structurally abnormal 
metaphase of chromosome chromosomes 
analyzed 
1 10 45 del(9)(pl2) 
2 10 50-52 i(lq) 
3 10 48 del(5)(p231) 
4 10 54-57 
5 10 54-56 unidentified abnormal 
6 10 48-50 ？i(2q)； ？lq+ 
�. 10 49 del(l) (q212) 
8 10 58-60 4q+ 
9 10 61 t(3;ll)(pl21;ql31) 
17p+ 
10 10 61-61 
11 10 72-74 del(l)(q32); 
unidentified abnormal 




The modal number of chromosome was 45 with a range of 41-
48. The consistent feature of karyotype was the following 
deviations from a hypodiploid complement: two del(9)(pl2) 
marker chromosomes replacing the normal chromosomes 9, 
which were chromosome 9 with a deleted short arm at band 
pl2. In addition, there were three copies of chromosome 1 
and 3, one copy of chromosome 6, 16, and 17, respectively. 
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Figure 4.1.1 
Karyotype of G-banded metaphase cell from Case 1 showing: 45, 
XX, +1, +3, -6, -9, -9, +del(9)(pl2), +del(9)(pl2), -16, -17. 




The modal number of chromosome was 50-52 with a range of 
40-57. One chromosome 1 was replaced by an i(lq), which 
was an isochromosome for the long arm of chromosome 1. In 
all metaphases, two or three normal chromosomes 2, 3, 19, 
20, 21, and 22 were seen, whereas, one or two normal 
chromosome X were absent. —^ ��-
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Figure 4.1.2 
Karyotype of G-banded metaphase cell from Case 2 showing: 
50,-X-X, -1, +i(lq), +2, +3, +19, +20, +21, +22. Structural 




The modal number of chromosome was 48 with a range of 39-
57. One chromosome 5 was replaced by an del(5)(p23), which 
was a chromosome 5 with a deleted short arm at band p23, 
and there ware three unidentified acrocentric chromosomes 
with the size of G-group chromosome. Three normal 
chromosomes 3, 15, 19, 20, and 21 were seen, whereas, one 
or two normal chromosomes 13 and X were absent. 
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Figure 4.1.3 
Karyotype of G-banded metaphase cell from Case 3 showing: 
48,-X-X, +3, -5, +del(5) (p23) , -10, -13, -13, +15, -17, +19, 
+20, +21, + unidentified mars. Structural rearrangements are 
^ indicated by arrows. 
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Case 4 
The modal number of chromosome was 55-57 with a range of 
49-60. No chromosomes with abnormal structure were seen. 
The following chromosomes were overrepresented in all 
metaphases: three copies of chromosomes 3, 4, 7, 8, 10, 13, 
14, 15, and 16, four copies of chromosomes 19 and 20. 
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Figure 4.1.4 
Karyotype of G-banded metaphase cell from Case 4 showing: 
56,XX, -1, +3, +4, +7, +8, +10, +13, +14' +15, +16, -18' +19' 




The modal number of chromosome was 54-56 with a range of 
42-60. A large acrocentric marker which may be derived from 
A - group chromosome was seen in 5 of 10 metaphases. In 
addition, three or four copies of chromosomes 4, 5, 13, 14, 
16, 17, and 20 were seen, but there was only one copy of 
chromosome 3. 
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Figure 4.1.5 
Karyotype of G-banded metaphase cell from Case 5 showing: 
54,XX, - 3, +4, +5, +13, +14, +16, +16, +17, +20, +LAM. 




The modal number of chromosome was 48-50 with a range of 
46-52. A large metacentric marker or a large 
submetacentric marker chromosome was seen in all 
metaphases. The metacentric probably was derived from A-
group chromosome and resembled that of an i(2q). 
However, the submetacentric appeared to be composed of a 
chromosome 1 with unknown material translocated onto the 
long arm. The normal chromosomes were present in two copies 
except 1, 2, 10, 12, 19, 21 (two or three copies), 3 (one 




1) I I W XHX K U j 
i ^ ^ 
K t | 墓 暮 鳥 畜 I I & « « 
a 
• * 竃禱 羼蓦 •• 
n 1 4 I B 1 6 1 7 n • “ r 
2 1 2 2 X H 
19 2 0 
2) 
U K B H M ftA 
3 4 5 
H I I 猓 M M • 麵 • 藝 暴 
3 7 8 9 10 n 12 
命 鳥 • 德 « • t t 
1 5 1 6 1 7 ” 
13 “ ” 鐘 4 
mm I T霧•浦 • • 霍 • • 驅 薦 1 
21 22 X • 1 9 2 0 • 
Figure 4.1.6 
Karyotype of G-banded metaphases cells from Case 6 showing: 
1) 50,XX, +1, +2, -3, -6, +10, +17, +19, +Marl. 2) 48,XX, -3, 
+12, -13, -14, +20, +20, +21, +Mar2. Structural 
rearrangements are indicated by arrows. 
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Case 7 
The modal number of chromosome was 49 with a range of 33-
51. One chromosome 1 was replaced by a del(1)(q212), which 
was a chromosome 1 with a deleted long arm at band q212. In 
addition, three copies of chromosomes 2, 5, 7, 8, and 10 
were seen, however, there was only one copy of chromosomes 
9, 18. 
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Figure 4.1.7 
Karyotype of G-banded metaphase cell from Case 7 showing: 
49,XX, -1, +del(l) (q212) , +3, +5, +7, +8, -9, +10, -18. 
< Structural rearrangement is indicated by arrow. 
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Case 8 
The modal number of chromosome was 58-60 with a range of 
48-62. A 4q+ chromosome with unidentified material on its 
long arm was present. Among the normal chromosomes, four or 
five copies of chromosomes 16, 20, three copies of 
chromosomes 1, 2, 3, 4, 5, 9, 13, and one or two copies of 
chromosome 18 were seen. 
84 
dH feft H hM m m h 
6 7 8 9 1 0 1 1 1 2 
翁 幾 耗 ^ ^ —， # 
i 
1 3 1 4 1 5 1 6 1 7 1 8 
〜 — （ # m . “ 、 神 ® 
1 9 2 0 2 1 2 2 X 
i -
Figure 4.1.8 
Karyotype of G-banded metaphase cell from Case 8 showing: 
58,XX, +1, +2, +3, +4, +4q+, +5, +9, +13, +16, +16, -18, +20, 




The modal number of chromosome was 61 with a range of 46-
64. A translocation chromosome derived from 3q and llq, 
t(3;ll)(3qter--pl21::llql31--qter) and a 17p+ chromosome 
with unidentified material on its short arm were present. 
In addition, four copies of chromosomes 1, 3, 7, 15, three 
copies of chromosomes 2, 4, 5, 6, 12, 14, and one copy of 
chromosomes 21 and X were seen. 
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Figure 4.1.9 
Karyotype of G-banded metaphase cell from Case 9 showing: 
61,X,-X, +1, +1, +1, +2, +3, +3, +t(3;ll)(pl21;ql31), +4, +5, 
+ 6, +7, +7, +12, +14, +15, +15, +17p+, -21. Structural 




The modal number of chromosome was 61-62 with a range of 
50-64. No chromosomes with abnormal structure were seen. 
The normal chromosomes were present in two copies except 
chromosomes 5, 10, 11, 15, 16, 17, 19, 20, (three copies), 
8, 12 (four copies), and 4 (five copies). 
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Figure 4.1.10 
Karyotype of G-banded metaphase cell from Case 10 showing: 
61,XX, +4, +4, +4, +5, +8, +8, +10, +11, +12, +12, +15, +16, 
+17, +19, +20. 
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Case 11 
The modal number of chromosomes was 72-74 with a range of 
67-74. In addition to two normal chromosome 1, there was a 
marker chromosome del(l)(q32), which was a chromosome 1 
with a deleted long arm at band q32. One large acrocentric 
marker chromosome which may be derived from A-group 
chromosome was present. Most chromosomes were represented 
. _ _ _ •辛 - * r -
by three copies with the exception of chromosomes 8, 12, 19 
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Figure 4.1.11 
K a r y o t y p e o f G - b a n d e d m e t a p h a s e c e l l f r o m C a s e 1 1 s h o w i n g : 
68,XX, +del(l) (q32) , +2, +3, +4, +5, +6, +7, +9, +10, +11, 
+ 13, +14, +15, +16, +16, +17, +17, +18, +20, +21, +22, +LAM. 




The modal number of chromosome was 90 with a range of 88-
101. A translocation chromosome between a 2 and 3, 
t(2;3) (2qter~qll: :3q2 3~qter) and a del(7)(q22) marker 
chromosome, which was a chromosome 7 with a deleted short 
arm at band q2 2, were present. Most chromosomes were 
represented by three copies with the exception of 15, 
(two or three copies) , 1, 12 (four copies), 3, 5, 11, 
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Karyotype of G-banded metaphase cell from Case 12 showing: 
90,XX, +1, +1, +2, +t(2;3) (qll;q23), +3, +3, +3, +4, +4, +4, 
+5, +6, +6, +6, +6, +7, +del(7)(q22), +8, +10, +10, +10, +10, 
. + 1 1 , +11, +11, +12, +12, +13, +14, +16, +17, +17' +17, +18, 
+ 18, +18, 19, +19, +20, +20, +20, +21, +22. Structural 
rearrangements are indicated by arrows. 
93 
4.1.2 Uterine corpus cancer 
Cytogenetic studies were performed on the uterine 
corpus cancer specimens from three patients with endometrioid 
carcinoma (Case 13-15) and one with leiomyosarcoma (Case 16). 
Chromosome counts showed that one of tumour was hypodiploid, two 
were hyperdiploid, and one was hypotriploid. The cytogenetic 
observations are summarized in Table 4.1.3, and the karyotypes of 
all cases are presented in Figures 4.1.13-16. 
� 
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Table 4.1.3 Cytogenetic features of uterine corpus cancer 
Case Number of Modal number Structurally abnormal 
metaphase of chromosome chromosomes 
analyzed 
1 10 28-47 del(ll)(pill) 
2 10 38-54 del(4)(q313)； ring 
3 10 58 t(ll;3)(ql31;pll) 
4 10 66-68 del(4)(pll)； 2q+ 
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Case 13 
The modal number of chromosome was 45 with a range of 27-
47. A marker chromosome del(11)(pill), which was a 
chromosome 11 with a deleted short arm at band pill, was 
seen. Two copies of the normal chromosomes were present, 
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Figure 4.1.13 
Karyotype of G-banded metaphase cell from Case 13 showing: 
45,XX, +4, +7, -8, -10, +del(ll)(pill), -18' -21. Structural 
rearrangement is indicated by arrow. 
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Case 14 
The modal number of chromosome was 54 with a range of 38-
54. There was a marker chromosome del(4)(q313>, which was 
a chromosome 4 with a deleted long arm at band q313, and a 
medium-sized ring chromosome. Two copies of the 
normal chromosomes were present, with the exception of 4, 
5, 8, 13, 14, 16, 19, 22 (three copies), 15 (three or four 
copies), X (one or two copies) and two normal 
chromosome 12 were absent. 
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Figure 4.1.14 
Karyotype of G-banded metaphase cell from Case 14 showing: 
54,X, -X, +del(4) (q313) , +5, +8, -12, -12, +13, +14, +15, 
+15, +16, +19, +22, +ring. S t r u c t u r a l rearrangements are 
< indicated by arrows. 
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Case 15 
The modal number of chromosome was 58 with a range of 54-
67. A translocation chromosome composed of llq and 3p, 
t(ll;3)(llqter--ql31::3pll--pter) was present. Three 
copies of the normal chromosomes were present, with the 
exception of 2, 5, 6, 9, 12, 16 (two copies) , 13, 15, 18, 
20 (four copies), 7, 11 (one copy), and normal chromosomes 
3 and X were absent• 
< � 
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Figure 4.1.15 
Karyotype of G-banded metaphase cell from Case 15 showing: 
58, -X-X, +1, _3, _3, +t(ll;3)(ql31;pll), +4, _7, +8, +10, _ 
11, +13, +13, +14, +15, +15, +17' +18' +18' +19' +20, +20, 
< +21, +22. Structural r e a r r a n g e m e n t is indicated by arrow. 
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Case 16 
The modal number of chromosome was 66-68 with a range of 
58-72. Two marker chromosomes del(4)(pll), which were 
chromosome 4 with a deleted short arm at band pll and one 
marker chromosome 2q+ with unknown material translocated 
onto the long arm were present. Four copies of the normal 
chromosomes were present, with the exception of 1, 3, 8, 
10,16,17 (three copies), 4,5,6, 9, 12,19 (two copies) and 7 
(one or two copies) , and normal chromosomes 2 and X were 
absent. 
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Figure 4.1.16 
K a r y o t y p e of G - b a n d e d metaphase cell from Case 16 showing: 
66,-X-X, +1, -2, -2, +2q+, +3, +del(4)(pll), +del(4)(pll),-
7, +8, +10, +11, +11, +13, +13, +14, +14, +15, +15, +16, +17, 
+ 18, +18, +20, +20, +21, +21 , +22 , +22 . Structural 
rearrangements are indicated by arrows. 
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4.1.3 Ovarian cancer 
Cytogenetic studies were performed on 4 cases with ovarian 
cancer. Chromosome counts showed that one of the tumour was 
hypodiploid, three were hyperdiploid. The cytogenetic 
observations are summarized in Table 4.1.4, and the karyotypes of 
all cases are presented in Figures 4.1.17-20. 
^ � 
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Table 4.1.4 Cytogenetic features of ovarian cancer 
Case Number of Modal number Structurally abnormal 
metaphase of chromosome chromosomes 
analyzed 
1 10 44-45 ？t(13;13)(13q;13q) 
unidentified abnormal 
2 10 49 del(l)(q32) 
del(ll)(pl3) 
3 10 52-56 unidentified abnormal 




The modal number of chromosome was 44-45 with a range of 
25-52. A large acrocentric marker chromosome of uncertain 
origin and ？Robertsonian translocation, t(13ql3q) was 
seen. Two copies of the normal chromosomes were present, 
with the exception of 2, 3, 6, 7, 10 (two or three copies), 
1, 5, 14, 18, 19, 20 and X (one or two copy). 
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Figure 4.1.17 
Karyotype of G-banded metaphase cells from Case 17 showing: 
1) 44,X, - X, -1, +3, -5, +6, +7, +10, -14, -18, -19, -20, 
+LAM. 2) 45,XX, +2, -13, -13, +t(13ql3q), -20. Structural 
rearrangements are indicated by arrows. 
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Case 18 
The modal number of chromosome was 49 with a range of 42-
73. One del(1)(q32) marker chromosome replacing the 
normal chromosome 1, which was a chromosome 1 with a 
deleted long arm at band q32, was seen. There was also a 
del(11)(pl3) marker chromosome replacing the normal 
chromosome 11, which was a chromosome 11 with a deleted 
short arm at band pl3 . Two copies of the normal 
chromosomes were present, with the exception of 4, 6, 8, 
12, 16 (two or three copies), 10 and X (one or two copies). 
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Figure 4.1.18 
Karyotype of G-banded metaphase cell from Case 18 showing: 
49,X, -X, +del(l) (q32) , +4, +6, +8, -10, -11, 
+del(11)(pl3), +12, +16. Structural rearrangements are 
(indicated by arrows. 
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Case 19 
The modal number of chromosome was 52-56 with a range 44-
72. One or two large acrocentric marker chromosomes which 
may be derived from A-group chromosome were present in all 
metaphases. Two copies of the normal chromosomes were 
present, with the exception of 19, 20, 21, 22 (four 
copies) , 1, 11, 16 (three copies) , 6, 9 (two or three 
copies) 4, 7 and 15 (one or two copies)• 
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Figure 4.1.19 
Karyotype of G-banded metaphase cell from Case 19 showing: 
60, XX, +1, -4, +6, +9, +11, -15, +16, +17' +19' +19' +20, 
+ 20, +21, +21, +22 , +22 , +LAM, +LAM. Structural 
鴻 rearrangements are indicated by arrows. 
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Case 20 
The modal number of chromosome was 53 with a range of 44-
56. A del(8)(pl2) marker chromosome replacing the normal 
chromosome 8, which was a chromosome 8 with a deleted short 
arm at band pl2, was seen. Two copies of the normal 
chromosomes were present, with the exception of 3, 4, 5, 7, 
14, 19 and 21 (three copies). 
一 ？ -
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Figure 4.1.20 
Karyotype of G-banded metaphase cell from Case 20 showing: 
53,XX, +3, +4, +5, +1, _8, +del (8) (pl2) , +14, +19, +21. 
Structural rearrangement is indicated by arrow. 
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4.2 Cytogenetic features of ovarian clear cell carcinoma 
cell line 
Karyotypes from twenty representative cells in each passage 
(P6, P30, P50, P80 and PllO) of ovarian clear cell carcinoma 
cell line OCCl were analyzed. The number of c e l l s analyzed and 
the modal number of chromosome found in each passage are 
summarized in Table 4.2.1. Most tumour cells from OCCl cell line 
were in the hypertriploid range, with a modal chromosome number 
of 74-78. 
'""Twelve marker chromosomes, both aberration origin identified 
a n d u n i d e n t i f i e d , w e r e f o u n d . T h e s e i n c l u d e n i n e i d e n t i f i e d 
chromosomal markers, t(l;14)(q21;122), del(l)(pl3), t(7 ; ? ) , 8p+, 
del(9) (p23) , del(12 ) (pl2) , 12q+, 16p+, der(17 ) , and three 
unidentified chromosomal markers, MIO, Mil and M12. MlO shows a 
d e l e t i o n o f a F - g r o u p c h r o m o s o m e . M i l a p p e a r s t o b e a R o b e r t o n i a n 
translocation of the two G-group chromosomes. M12 resembles 
chromosome 21, except that it is different in its size. 
S t r u c t u r a l r e a r r a n g e m e n t s o f m a r k e r c h r o m o s o m e o c c u r r e d i n n e a r l y 
all five passages, while two new marker chromosomes 12q+ and MlO 
first appear in P80 and PllO. A b n o r m a l i t i e s of these marker 
chromosomes include deletions, translocation, isochromosome, and 
more complex rearrangements. 
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A summary of chromosomal structural analysis in the five 
passages of OCCl cell line is shown in Table 4.2.2. Ten marker 
chromosomes appeared in all five passages are shown in Figure 
4.2.1. Representative karyotypes for P6, P50 and P80 are given in 
Figures 4.2.2-4. The marker chromosomes from P80 and PllO are 
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Table 4.2.2 Summary of cytogenetic findings from all five 
passages 
Marker Structural aberration Incidence(%) 
chromosome 
Ml t(l;14)(q21;q22) 100% 
M2 del(l)(pl2) 100% 
M3 t(7;?) 100% 
M4 8p+ 100% 
a 
M5 del(9)(p23) 100% 
M6 del(12)(pl2) 100% 
M7 16p+ 100% 
M8 der(17) 100% 
b ‘ 
M9 12q+ 50% 
b 
MIO unidentified 50% 
Mil unidentified 100% 
M12 unidentified 100% 
a 
i(9q) was found in a few cells. b 
Acquisition of markers were present in the 80 and 110 passages 
only, 
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Figure 4.2.1 
Partial karyotype of one cell from OCCl cell line P30 showing 
marker chromosomes which also appeared in other four 
^ passages, i.e. P6, P50, P80 and PllO. Normal chromosome are 
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Figure 4.2.2 
Trypsin-Giemsa banded karyotype of one cell from the OCCl 
cell line P6 showing hypertriploid chromosome constitution, 
• which includes identified and unidentified markers. 
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Figure 4.2.3 
Trypsin-Giemsa banded karyotype of one cell from the OCCl 
cell line P50 showing hypertriploid chromosome constitution, 
"which includes identified and unidentified markers. 
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Figure 4.2.4. 
Karyotype of one cell from the OCCl cell line P80 showing 
hypertripoid chromosome constitution. The arrow indicates a 
雀 acquisition of marker MIO. 
121 
、 、 、 書 』 ^ ^ ^ 
J •• 7 � ^ ^ ^ JH • • 
Figure 4.2.5 
Metaphase spread of a cell from PllO showing presence of 
acquisition of markers [ql2+ and MIO] (arrows). 
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5.1 Methodology of chromosome preparation in solid tumour 
Cytogenetic analysis of solid tissue can be performed using 
either short-term cell culture or direct chromosome preparation 
from tumour cells. Both techniques have advantages and drawbacks. 
Cell cultures allow high-resolution banding, however, cells must 
be cultured for 5-10 days prior to harvest and analysis. Direct 
chromosome preparations offer the advantages of rapid results and 
low risk of contamination (Simoni et al., 1983). Chromosome 
resolution with direct preparations, however, may not always 
alriow detection of subtle structural chromosome changes. 
In this study, the approaches to the analysis of chromosome 
changes in solid tumours are continuously undergoing modification 
and evolution, with the hope that ultimately an optimal technique 
can be established. A modified method adopted from chromosome 
preparation of chorionic villus was developed and used to study 
solid gynaecological tumours (Method 3). This thesis presents 
this simple direct method that requires 10 mg or less of tumour 
tissues and consistently yields analyzable metaphases of tumour 
cells and increases the efficiency of results on chromosome 
changes in solid tumours. Since the establishment of an improved 
method of direct chromosome preparation, 20 cases with 
gynaecological tumours have successfully obtained metaphases and 
chromosomal banding for use of cytogenetic analysis. 
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Establishment of karyotypes in solid tumours has been greatly 
hampered in the past by the unavailability of methods leading to 
high yields of dividing cells suitable for cytogenetic analysis, 
including banding with various techniques. A comparison of the 
cytogenetic results obtained in the present study with tumour 
cell suspensions from gynaecologic tumour tissues showed that the 
latter generally yielded a higher number of metaphase cells and 
considerably improved the quality of banding. 
Modification of the fixation procedure increases the number 
of intact metaphases in the chromosome preparations (Mogens, 
1984) . The pre—fixation used in this study was carried out for 
two purposes: (1) to make metaphases more resistant to mechanical 
stress and (2) to prevent the shrinking of metaphase by the 
gradual change from water to the methanol/acetic acid phase 
(Mogens, 1984). Poor chromosome banding is generally caused by 
the effect of acetic acid (Tharapel et al., 1986; Cheung et al., 
1987), which has the characteristic of making tissue expanded, 
therefore, causes the chromosome swelling, and makes banding very 
difficult. However, the expansion effect of acetic acid can be 
paftly counteracted by the contraction effect of methanol in 
conventional fixation. The key to this problem is to free the 
chromosome from the excessive effect of acetic acid. In this 
study tumour cells were dissociated after an additional short-
term pre-fixation which made the cytoplasm swell more gradually. 
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Thereafter, the partly swollen cytoplasm surrounding the 
chromosomes can mediate the effect of acetic acid and thus reduce 
damage to the chromosome. 
Another modification in this method of chromosome preparation 
from solid tumours was that the cell filtration by steel sieve 
was carried out after fixation. This reduced the cell loss and 
provided a sufficient number of metaphases from a sample for 
genetic analysis. 
The results suggest that this simple method of chromosome 
preparation may be used not only for solid gynaecological 
tumours, but also for other types of solid tumour, to obtain 
sufficient numbers of metaphases and high-resolution banding 
patterns for genetic analysis. 
5.2 Chromosome changes in gynaecologic solid tumour 
5.2.1 Cervical cancer 
Regarding carcinoma of the cervix, several reports on 
primary and metastatic tumours have outlined a pattern of 
chromosomal involvement. Atkin and Baker (1979) described 26 
cases of carcinoma of the cervix with numerical and structural 
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alterations of chromosome 1. In their two papers, they further 
reported data on 9 near-diploid tumours of the cervix and 10 
near-triploid or tetraploid tumours of the cervix, where 
chromosomes 1, 3, 5, 6, 11 and 17 were involved (Atkin and Baker, 
1982; 1984). Van der Riet-Fox et al.(1979) found alterations in 
chromosomes 1, 6, 9, 11 and 17 in 6 cervical cancers. Common 
feature of carcinoma of the cervix is the presence of high ploidy 
chromosome numbers, which have been observed by these 
investigators. 
In this study the results of cytogenetic analysis from 12 
cases of cervical cancer showed both numerical and structural 
alterations were found. Structural abnormalities in chromosome 1 
were present in four tumours as consistent features of the 
metaphases. Chromosomes 2 and 3 had undergone structural changes 
in two tumours, and other possibly nonrandom structural changes 
involved in chromosomes 4, 5, 7, 9, 11 and 17. 
Chromosome 1 is the chromosome most frequently involved in 
human cancer and leukemia (Atkin, 1986). Its association with the 
malignant process has been stressed repeatedly. Aberration of 
this chromosome have been reported in a variety of malignancies 
from lung, bladder, breast, testes, prostate, kidney, colorectum, 
skin soft tissue, and hematologic origin. From these data and 
the published literature, numerical and structural changes of 
chromosome 1 constitute one of the most common karyotypic 
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alteration in carcinoma of the cervix. 
In this study, isochromosome of the long arm, deletions of 
the long arm, and translocations in chromosome 1 were observed 
in four of twelve cervical cancers in this study. Isochromosomes 
of the long arm occur more frequently (Atkin and Baker, 1979 ； 
1982 ； 1984), though isochromosomes 1 of both the long and short 
arms were observed in cervical cancer. In other tumours, short 
arm isochromosomes are also relatively rare, The long arm 
chromosome abnormality, i(lq), is a common nonrandom karyotypic 
change which also has been observed in leukemia (Sandberg, 1980). 
Among solid tumours, i(Iq) was common to tumours of the breast 
(Kovacs, 1978), colon (Reichmann et al,, 1984), ovary (Trent and 
Salmon, 1981), bladder (Atkin and Baker, 1985) and melanomas 
(Kakati et al,, 1977). 
The nonrandomness of chromosome 1 involvement in human 
cervical carcinoma is of special importance because five 
oncogenes have been mapped to this chromosome. The oncogenes B-
Lym-1 and L-myc have been localized to band lp32 (Morton et al., 
1984 ； McBride et al, , 1985) . N-ras has been assigned to band 
lpll-pl2 (Pettenati et ai., 1985), c-src to Ip34-p36 (Le Beau et 
al. , 1984), and c-skl to Iq22-q24 (Chaganti et al, , 1986) . Nine 
fragile sites also have been located on chromosome 1(lp36,lp312, 
lp22, Ip212,lq213, lq251, lq42, and lq441 (Berger et al. , 1985). 
In addition, genes for nucleic acid synthesis are locatized on Iq 
(Helsinki conference, 1985). All of the above oncogene sites and 
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fragile at bands or regions frequently involved in the 
aberrations. However, whether or not these oncogenes have a role 
in the transformation and progression of cervical carcinoma 
remains to be determined. A correlative study of oncogene 
activity at the molecular level might help to verify the role of 
nonrandom structural chromosome changes in neoplasia. 
Chromosome 17 had undergone structural changes in one case of 
cervical cancer (Case 8) in this study. In most other types of 
tumour, rearrangements of this chromosome appear less common, in 
particular, 17p+ chromosome has rarely been described (Atkin and 
Baker, 1989). As suggested for the colorectal carcinomas, the 
critical event may be the loss of a recessive gene or genes on 
17p (Testa and Cohen, 1986). However, it is possible that the 
presence of extra copies of 17q may alternatively or additionally 
be important. The c-erb-A protooncogene is situated on 17q (Spurr 
et al. , 1984), but no known oncogene has been located on 17p, 
although the anti-oncogene encoding p53, a protein that is 
frequently overproduced in tumours and transformed cell lines, 
has been mapped to 17pl3 (McBride et al., 1986). 
" In two tumours (Cases 3 and 10) the appearances suggested an 
origin from a chromosome 5 or 4 that had undergone short arm 
deletion and long arm translocation derived from unknown 
material. Similar small markers have been described by other 
investigators (Atkin and Baker, 1984; Barbich et al., 1985). 
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Among possible etiologic agents, herpes simplex viruses (HSVs), 
particularly HSV-2, may also play a part of role in cervical 
carcinogenesis (McDougall et al., 1984). HSV-1 sequences were 
probably integrated into chromosome 5, and the HSV-2 thymidine 
kinase gene was associated with a probable i(5p) and with a 
chromosome 17 having a short-arm translocation derived from 
chromosome 21 or 18 in cells of HeLa origin (Kit et al,, 1981). 
Human papillomaviruses (HPVs) have recently received prominence. 
Several reports have described the chromosome integration sites 
of HPVs in HeLa and other cell lines derived from cervical 
cancers. At least eight different chromosomes have been 
implicated, 11 sites of HPV16 integration in chromosomes 3, 5, 8, 
9, 13, 20, and 22 (Mincheva et al• 1987). 
Chromosome 3 had undergone structural changes in two tumours, 
and t(3;ll)(3pl21;llql31) (Case 9) and t(2;3)(2qll;3q23) (Case 
12) were present in this study. The break point on chromosome was 
variable. It was on the short arm (pl21) and on the long arm 
(q23). Although these findings might not necessarily be the same 
as those present in the primary tumour, they may indicate the 
karyotypic evolution of the tumour and increased complexity of 
th^ cytogenetic features of these cases. 
Other nonrandom structural changes were found in chromosome 
7 and 9 (Case 12 and Case 1). There were small acentric fragments 
and large acrocentric marker chromosomes, present in duplicate in 
three tumours (Cases 3, 5 and 11). In Case 10, there was a large 
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metacentric marker or a large submetacentric marker chromosome, 
which may be derived from one or two A-group chromosome. The 
metacentric resembled of an i(2q) and the submetacentric 
appeared to be composed of a chromosome 1 with unknown material 
translocated onto the long arm. The presence of these fragments 
and marker chromosomes suggests that they represent some 
markers that have some degree of specificity for carcinoma of the 
cervix. However, this question cannot be resolved because their 
origins could not be determined, as it might be different in 
different tumours. Owing to the limitation of chromosomal banding 
analysis in itself, apparent fragment and marker chromosome must 
be一，studied by molecular means for firmer establishment of their 
identity. 
In all twelve cases of cervical cancer, there were trisomies 
or over trisomies chromosomes 1 (five tumours), 2 (seven 
tumours), 3 (six tumours), 4 (seven tumours), 5 (seven tumours), 
10 (six tumours), 15 (six tumours) , 16 (six tumours), 17 (six 
tumours) , 19 (six tumours) and 20 (nine tumours), while 
monosomies chromosome 6 (two tumours), 9 (two tumours), 13 (two 
tumours), 18 (three tumours), and X (three tumours). Thus, 
considering the near-diploid and triploid-tetraploid tumours 
together, chromosome 1, 2, 3, 4, 5, 10, 15, 16, 17, 19, 20 and 21 
were frequently overrepresented, while chromosome 6, 9, 13, 18 
and X tended to be underrepresented. 
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The findings from this study indicate that chromosome 
aberrations in cervical cancer typically are very complex. 
Chromosome 1 was most frequently involved in structural 
abnormalities, total or partial trisomy of chromosome 1 might 
provide a selective advantage similar to that resulting from the 
other structural changes present in the majority of samples of 
this tumour type. The presence of chromosome 1 aberrations in 
early malignancy or premalignant lesions as in cervical cancers 
(Atkin et al. , 1983; Sreekantaiah et al, , 1987), however, 
suggests that this might constitute an initiating event in the 
premalignant state and subsequent progression to the invasive 
form of the cancer. The use of DNA probes and restriction enzymes 
for gene mapping may provide more in formation to define the 
precise contribution of specific chromosome abnormalities to 
oncogenesis and tumour growth (Pearson et al., 1983). 
5.2.2 uterine corpus cancer 
In this study, cytogenetic evidence of malignancy, depicted 
n 
by deletions and translocations in three cases of endometrial 
adenocarcinoma and one case of leiomyosarcoma. Chromosomes 4 and 
11 had undergone structural changes in two tumours, other 
nonrandom structural changes involved in chromosomes 2, 3 and an 
unidentity ring marker. 
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This study showed that translocation between chromosomes 11 
and 3, t(ll;3) (ql31;pll) , and trisomy for the long arm of 
chromosome 11, observed in endometrial adenocarcinomas (two 
cases)• The association between chromosomal rearrangements and 
oncogenes, including their loci and activity, and their roles in 
tumorigenesis have been discussed (Yunis, 1983). Yoshida et ai. 
(1986) reported that the translocation between chromosomes 1 and 
11 might be associated with the redevelopment of the tumour, 
because a human protooncogene {c-ets) has been mapped to region 
q23-q24 of chromosome 11 (de Taisne et al., 1984). Rearrangements 
involving the oncogenic site of chromosome 11(q23-24), have been 
一 • ？ 
described in acute leukemia, t(9;11)(p21;q23, t(11;19)(q23;pl2 or 
ql2)(Oshimura et al,, 1976; Prigogina et al., 1979; Hagemeijer et 
al. , 1982), and in Ewing's sarcoma, t(11;12)(q24;ql2) (Aurias et 
al. , 1984). It remains to be demonstrated in which of these 
conditions, including endometrial cancer, the oncogene is 
directly involved. But no known oncogene has been located on 
pill and ql31 of chromosome 11, although the oncogene c-ets 
mapped to region q23-q24 of chromosome 11. 
"This study confirms that these tumours are generally near-
diploid and are characterized by trisomies or tetrasomies. 
Trisomies or tetrasomies chromosome 10 have been reported 
previously in endometrial adenocarcinoma (Fujita et ai., 1985; 
Couturier et al., 1988b) but have not received as much attention 
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as alterations to chromosome 1 in the context of this neoplasia. 
In this study trisomy 10 was found in one cases. Simon et al. 
(1990) reported that abnormalities of chromosome 10 were present 
in some cases where chromosome was the only aberrant chromosome. 
They would not be of help in understanding the origin of the 
cellular defect that leads to this particular neoplasia. From 
this aspect, the focus of research should be on the early stages 
of the malignancy. The genes of interest on chromosome 10 that 
have been mapped and that could play a potential role in 
endometrial adenocarcinoma are the interleukin-2 (IL-2) receptor 
(Malkovsky and Sondel, 1987), which maps on 10pl4-pl5, and human 
cytochrome p-450 PB-1. The latter has recently been mapped to 
chromosome 10 and plays a physiologic role in mephenytoin and 
steroid oxidations (Meehan et al. , 1988). However, possible 
alterations to either of these genes remain to be evaluated at 
the molecular level. So far, no human protooncogene has been 
mapped to chromosome 10. Further studies are required to confirm 
the role of chromosome 10 as the primary chromosome change in 
endometrial adenocarcinoma and to determine, at the molecular 
level, the particular gene locus that is involved in this 
malignant alteration. 
Fujita et al. (1985) reported that partial trisomy or 
tetrasomy long arm of chromosome 1 was observed in every 
endometrial carcinoma cell, but not in cells from endometrial 
hyperplasia or the case of a mixed mesodermal tumour. Milatovich 
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et al. (1990) also reported that abnormality of chromosome 1, 
trisomy or tetrasomy of Iq was present in 71% of stage I 
endometrial adenocarcinoma. These results suggested that a 
rearrangement of chromosome 1 in endometrial carcinoma was 
probably not produced as a result of genetic instability due to 
tumour progression, and suggested a possible relationship 
between chromosome 1 and early stages of endometrial 
adenocarcinoma. 
Unlike the majority of endometrial adenocarcinoma, trisomy or 
tetrasomy long arm of chromosome 1 was not observed in cells from 
this study, except for a trisomy chromosome 1 in one case. 
Although in endometrial adenocarcinoma, abnormalities of 
Chromosome 1 are quite common, in 30% of these stage I tumours 
the chromosomes are apparently normal (Milatovich et al. , 1990). 
Couturier et al, (1988b) believed that these normal cells were 
representative of the malignancy. They gave as an example one 
case of clonal evolution of an abnormal chromosome 1 that also 
had normal chromosomes 1 in some metaphases. They proposed that 
endometrial adenocarcinomas are initially chromosomally normal, 
then progress and develop chromosomal abnormalities. Sandberg et 
al\ (1988) suggested that the cytogenetically normal cells are 
probably the stromal cells that are part of the tumour. The 
metaphases that appeared to be normal might have been 
representative of the normal stromal and epithelial cells. 
Although the malignant cells might have been present and possibly 
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karyotypically abnormal, they were not cytogenetically observed 
owing to the low mitotic index of the malignant cells. 
In addition to these chromosomal changes, some other 
chromosome aberrations present identified or unidentified, 
deletion of the long arm in chromosome 4, breakpoint q313 and a 
medium-sized ring chromosome in one tumour (Case 14) . In these 
three cases of endometrial adenocarcinoma, there were trisomies 
or tetrasomies 4, 8, 13, 14, 15, 19 and 22 in two tumours, while 
monosomies 7, 11, 18 and X in one tumour and losses of chromosome 
12 and X in one tumour. Thus, considering chromosomes 4, 8, 13, 
14, 15, 19 and 22 were frequently overr epre sent ed, while 
chFomosomes 12 and X tended to be underrepresented. 
Leiomyosarcoma is rare neoplasm, representing one quarter of 
uterine sarcomas, or 1% of all malignant tumours of the uterus 
(Norris and Zaloudek, 1982). Karyotypic data on this tumour type 
is scarce, few uterine leiomyosarcoma have been cytogenetically 
characterized (Dal Cin et al. , 1988; Nilbert et al, , 1990) • In 
this study, the leiomyosarcoma of Case 16 had a hypotriploid 
karyotype with several rearrangements, of which the del(4)(pll) 
and 2q+ were structural change present in multiple copies. In 
addition to these chromosomal changes, some other chromosome 
number aberrations were present, trisomies or over-trisomies of 
chromosomes 1, 3, 8, 10, 11, 13, 14, 15, 16, 17, 18, 20, 21 and 
22 in three metaphases, and monosomies of chromosome 7 and X in 
four metaphases. 
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Nilbert et al. (1990) reported chromosome 4 changes in a 
metastatic leiomyosarcoma, t(4;7)(q21;q36) in two metaphases and 
t(4;17)(ql3;pl3) in three metaphases. The malignant striated 
muscle tumour (rhabdomyosarcoma) is characterized by the specific 
translocation t(2;13)(q37;ql4) (Douglass et al. , 1987; Wang-Wuu 
e亡 al • , 1988) . The karyotypic picture in this tumour type is 
diverse, often with complex numerical and structural changes. 
None of the chromosomal changes in the case reported here 
correspond to those previously found in leiomyosarcoma, or to 
known cancer-associated anomalies. 
In endometrial adenocarcinoma, apparently are both numerical 
and structural chromosomal alterations. Abnormalities of 
chromosome 3, 4, 10 and 11 were observed in three endometrial 
adenocarcinomas of this study. However this investigation did not 
show abnormality of chromosome 1, trisomy or tetrasomy of Iq to 
be specific for endometrial adenocarcinoma. Abnormalities of 
chromosome 2 and 4 were observed in one case of leiomyosarcoma. 
Elucidation of a possible role of this phenomenon in the 
neoplastic transformation of uterine leiomyosarcoma will require 
analysis of a large number of tumours. 
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5.2.3 Ovarian cancer 
There have been several previous cytogenetic studies on 
ovarian cancer using banding techniques (Trent and Salmon, 1981; 
Whang-Peng et al., 1984; Mitelman, 1988). From these reports 
sufficiently detailed karyotypic data are available on 
approximately 150 cases. Though almost every chromosome is 
involved in human cancer, those most frequently reported are 1, 
3, 5, 7, and 8 (Mitelman and Levan, 1981) . The most commonly 
reported karyotypic alterations in ovarian cancer are structural 
and numerical aberrations of chromosome 1, 3, 6 and 11 (Atkin 
andf Pickthall, 197 7; Trent and Salmon, 1981; Kusyk et al., 1982), 
whereas alterations of chromosomes 2, 4 and 5 have been observed 
less frequently. Among other chromosomes, rearrangements of 7, 
10, 11, 14 and 19 have been identified most frequently. 
In this study, a similar pattern was observed, but there 
were some exceptions. Abnormality of chromosome 1, del(1)(q32), 
and abnormality of chromosome 11, del(11){pl3) were seen in one 
case. In addition, abnormality of chromosome 13, ？ R o b e r t s o n i a n 
translocation t(13ql3q), del(8)(pl2), and one or two large 
acrocentric marker chromosomes which may be derived from A-group 
chromosome were each seen in one case. 
Chromosome 1 abnormalities appear to be the most common 
cytogenetic abnormal it ies in ovarian cancer and have been 
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reported in over 80% of the cases studied by chromosome banding 
(Whang-Peng et ai. , 1984) . Abnormalities of chromosome 1 
including duplications, deletions, translocations and 
isochromosome formation have also been reported by other authors 
(Atkin and Pickthall, 1977; Trent and Salmon, 1981; Kusyk et al., 
1982). The most frequent abnormality of the short arm was lp+, 
with the extra material of known or unknown origin. In the long 
arm, deletion of the band area q21 to q32 was the most common. 
The Case 18 in this study also showed to have this type of 
deletion, del(l)(q32). Rowley (1978) suggested that regions q25-
32 on chromosome 1 involved genes important in cell proliferation 
yielding a dosage effect, which might explain their widespread 
. 一 
occurrence in a variety of human tumours. 
Besides breakpoints on chromosomes 1, several other regions 
have been reported as recurring sites of chromosome 
rearrangements in ovarian cancer. Included among this is llpll-
13. Currently, intensive investigations are underway in a number 
of laboratories to determine whether protooncogenes located near 
the site of acquired chromosome rearrangements are altered in 
such tumours (Tanaka et al., 1989). 
In addition, abnormality of 13q, t(13ql3q) was seen in two 
metaphases in Case 1, abnormality of 8p- was seen in Case 4, 
whereas these abnormalities were seldom reported by other 
investigators. Whang-Peng et al. (1984) reported chromosome 
translocations between in D-group, including t(13;14), t(14;14), 
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t(14,.15) and i(14). Tanaka et al, (1989) reported breakpoints at 
8pll-21, but no known oncogene was located near this sites. One 
or two larger acrocentric marker chromosomes were also seen in 
two cases. Furthermore, the recurrence of specific regional 
chromosome losses suggests that these sites should be targeted 
for future molecular investigations. Chromosome changes seen in 
virally and chemically induced experimental tumours have been 
found to be specific depending on the carcinogen employed 
(Mitelman et al. , 1972). This situation has led to the 
speculation that chromosome changes in human tumours are likewise 
carcinogen-specific and that a particular stimulus will affect a 
certain chromosome region, it would also explain the finding of 
similar chromosome abnormalities in widely differing malignancies 
(Rowley, 1975). 
In four cases, an assessment of the normal chromosomes showed 
that chromosomes 1, 6, 11, 19, 20, 21 and 22 were frequently 
overrepresented, while chromosomes 5 and X tended to be 
underrepresented. As more cases of ovarian cancers are studied 
with banding analysis, consistent kaypotypic features may prove 
more common than previously recognized. 
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5.2.4 In summary 
Twenty cases of gynaecologic malignancy were cytogenetically 
studied. As noted above, a small number of chromosomes tend to be 
nonrandomly involved in structural changes in carcinomas, and it 
seems that while some chromosomes such as chromosome 1, 3, and 11 
are involved in most or all types of carcinoma, others may be 
more limited in their appearance and perhaps are uniquely 
associated with a particular type, such as chromosome 5 and 17 in 
cervical cancer, chromosome 10 in endometrial adenocarcinoma, 
and chromosome 8 in ovarian cancer. It is also noteworthy that 
thi§^  changes affecting a particular chromosome in a given type of 
tumour show considerable variation, translocation with varying 
partners and breakpoints, deletions and isochromosomes. A 
critical region of the chromosome may be consistently lost or 
duplicated as a result of the changes. 
In addition the relationship of clinical and pathologic data 
to the cytogenetic findings of these tumours was also considered. 
Due to limited number of cases in this study relationship between 
the cytogenetic results and age, grade or stage have not been 
shown. However in the literature there appeared to be no 
significant relationship between them. Fujita et al. (1985) 
reported no differences between the number and type of 
chromosomal abnormalities of tumours that were stage I and 
tumours of later stages. When age was considered as a prognostic 
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indicator, the patients were divided into two groups , age 30-60 
years and older than 60 years. There appeared to be no 
correlation of these parameters with the cytogenetic data in 
these studies (Couturier et al, , 1988a). Although the part that 
ploidy plays in a tumour is not entirely clear, the present 
results are evidently at variance with those of a previous report 
(Toews et al, , 1968). The latter authors suggested that well-
differentiated tumors tend to have a modal chromosome number in 
the diploid range and to have sharper single modes. Whereas 
poorly differentiated tumours had modes in the triploid range. 
Hypodiploid cells were assumed to originate either from 
hypierdiploid cells through chromosome loss or by an evolutional 
pathway which is completely different from that of the 
hyperdiploid cells. If the former were the case, it is reasonable 
to assume that the lower the chromosome number, the more probable 
the tumour is to be poorly differentiated. However, the stage in 
tumour development when the karyotypic analyses were performed 
may also be a possible cause of the variance (Wake et al,, 1980). 
In the case of most solid tumours, unfortunately, cytogenetic 
analysis has not yet provided the molecular geneticists with the 
information necessary to identify the critical genes involved in 
the malignant process. The molecular mechanisms in the malignant 
transformation of cells of solid tumours might involved in 
multiple steps, since these cells must escape several levels of 
different environmental controls and restrictions. Thus, it may 
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be difficult to find common cytogenetic differences in such 
tumour cells. However, quite likely, such nonrandom chromosomal 
alterations will be found, at least in some of the solid tumours, 
and will provide the basis for a rational molecular genetic 
approach to the pathogenesis of human solid tumours (Croce, 
1986). 
5.3 Chromosome changes in an ovarian carcinoma cell line 
Establishment of tumour cell lines has allowed biological and 
cytogenetic investigations of tumours. Both Sheer et al • (1987) 
and Tanaka et al. (1989) indicated that more cytogenetic studies 
on tumour cell lines and primary tumours should be performed, in 
order to further understand human tumourigenesis. In the present 
study, the ovarian carcinoma cell line (OCCl) is shown to be 
hypertriploid with a mean chromosome number of 74-78 (range 61-
88). Cells from all five passages had two normal X chromosomes, 
but structural abnormalities were demonstrated in the other 
chromosomes. 
In agreement with other studies (Smith et al., 1989/ Bello et 
al. , 1990) this study found that chromosomes 1, 7 and 9 were 
frequently rearranged. Rearrangements of chromosome 1 have been 
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associated with most malignancies with certain regions being more 
frequently involved than the others �Whang-Peng et al., 1984). 
These structural changes of chromosome 1 have also been 
demonstrated in ovarian carcinoma by direct methods, short-term 
cultures, and cultured cell lines (Smith et ai. , 1989) . In the 
present study, a specific translocation between chromosome 1 and 
14 (t(l;14) (q21;q22) and a deletion of chromosome lpl3 were 
present in cells from all five passages which suggested a 
prominent role of chromosome 1 in this histological type of 
ovarian cancer. Augustus et al.(1986) , who studied effusions 
derived from ovarian tumours, also indicated band q21 as the most 
frequent breakpoint. This has further been confirmed by Sheer et 
al. (1987) on permanent cell lines. Atkin (1986) considered that 
abnormalities of chromosome 1 were related to an event common to 
all neoplasia. 
Breakpoints identified on other chromosomes distributed 
nonrandomly. Translocation of chromosome 7, at breakpoint q22 was 
found in all five passages. Abnormalities of chromosome 7 in 
ovarian cancer have been reported, including deleted 7q in an 
ovarian cell line (Smith et ai. , 1987) and a 7p+ marker in a 
solid tumour (Panani and Ferti-Passantonopolou, 1985). 
In this study has also discovered deletion of the short arm 
of chromosome 9 at breakpoint p23 in all five passages of OCCl 
cell line. Abnormality of chromosome 9 in ovarian tumour has been 
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supported by previous studies. Kunzmann and Holzel (1987) 
reported two different rearrangements of 9pl3. Van der Riet-fox 
et al. (1979) described a papillary adenocarcinoma with 
rearrangement in a more distal region of 9p. Bello et al. (1990) 
reported deletions or translocations of 9p in five metastatic 
ascitic fluids. The relatively frequent involvement of the short 
arm of chromosome 9 also occurred in other neoplasias, acute 
lymphoblastic leukemia (Bloomfield et al. 1987) and malignant 
gliomas (Signer et al., 1988) Such relatively frequent 
involvement of 9p in human malignancy may suggest that certain 
genes important for neoplastic development are present in this 
region. 
. 一 
Abnormalities of chromosomes 8, 12, 16, and 17 also appeared 
in this study. A8p+ marker, deleted chromosome 12pl2, a 16p+ 
marker and a 17p+ marker were identified in all five passages. 
Alterations of chromosomes 8, 12, 16, and 17 have been reported 
in ovarian cancer. Breakpoints at chromosomes 8pll, 12q24, and 
16q24 were reported in solid tumours (Tanaka et al., 1989; Bello 
and Rey, 1990), and i(12p) chromosome in primary and metastatic 
ovarian tumours (Bello et al. , 1990). A 17q+ marker chromosome 
was found in a primary ovarian tumour, but i(17q) was found in 
both ovarian cancer and other malignancies (Panani and Ferti-
Passantonopolou, 1985). 
Reports of sequential studies on ovarian cell lines from 
other laboratories are limited (Smith et al, , 1989) . The 
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appearance of stable markers and translocations was reported by 
Hill et al., (1984) and Smith et al., (1989) respectively. These 
alterations may be related to the histological type and the 
disease stage (Smith et al, , 1989) . Data from Mark et al, (1987) 
and Smith et al,(1989) dealing with the analysis of glioma cell 
lines and ovarian cancer cell line at low passage levels and 
followed cytogenetically over long ranges of passages 
demonstrated that the duplication of the chromosomal complement 
of near-diploid cell populations leads to near-tetraploid modal 
numbers. The karyotypic analyses of those cell lines showed the 
same evolutionary patter, namely, duplication of the near-diploid 
stein line and further evolution to near-triploid modal numbers. 
Thus, chromosomal progression can explain why most established 
cell lines are triploid, starting from diploid tumoural cells. As 
an explanation, Bigner and coworkers (1987) proposed the 
possibility that a diploid cellular population present in primary 
tumours could have been selected by the in vitro culture 
conditions. 
In this study, OCCl cell line has shown stable hypertriploid 
and several translocations. This cell line retained the same 
markers for all five passages (P6, P30, P50, P80 and PllO), 
however with acquisition of two new markers (12q+ and MIO) in P80 
and PllO. The findings suggest that karyotypic evolution 
continues in culture over many passages, which is in agreement 
with the study of Smith et al. (1989) Who also documented that 
146 
genetic stability of cancer cells is variable after being 
cultured in vitro for a long time. The significance of 
acquisition of new marker chromosomes cannot by fully determined, 
but it was associated with prolonged culture in this study. The 
explanation for emerging new marker chromosomes remains unknown. 
Chromosomal evolution is a possible explanation, but cross-
cultural contamination might be another possibility (Urvashi and 
Habibian, 1989). The findings in this study also indicate that 
after many passages in culture the cytogenetic characteristics of 
the cells from a cell line can be changed, which may lead to the 
alterations of their biochemical properties. Therefore, the 
turnbur cells from a newly established cell line, even from fresh 
tumour tissue are preferable to be used for the study of 
tumourigenetics, tumourigenesis, or antitumour therapy. 
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Approximately 90% of all cytogenetic information available in 
human cancer hag been obtained from patients with leukemias and 
lymphoma, yet these represent only 3% of the total cancer 
incidence (Rowley, 1985). The major reason for this imbalance is 
the low mitotic yield and poor metaphase quality achieved in 
preparations from solid tumours. The bulk of cytogenetic 
information available for gynaecologic cancer is provided by the 
study of cell lines (Hill et al. , 1984; Buick et al, , 1985) or 
from direct preparations of ascites fluid cells (Whang-Peng et 
al. , 1984; Jenkyn & McCartney, 1987). However, ascites fluid 
cells may not be representative of the solid tumour from which 
they arise, and tissue culture selection may also result in a 
line that does not represent the original tumour. Clearly, 
studies of solid tumour tissue are preferable. The data available 
on gynaecologic solid tumour to date are limited, both in terms 
of the number of tumour specimens analyzed and in number and 
quality of metaphases karyotyped (Van der Riet-Fox et al. , 1979; 
Wake et al., 1981; Panani & Ferti-Passantonopoulou, 1985). This 
bias seriously hinders any attempt to formulate a general 
chromosomal theory of cancer. 
The modified method of chromosome preparation developed in 
this study appears superior for three reasons. Firstly, the 
technique described allows rapid and little risk of 
contamination. Secondly, the number of cells counted for 
chromosome number is generally high, and finally, this method 
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provides a greater number of cells suitable for karyotypic 
analysis. The technique may increase the potential for detailed 
cytogenetic analysis of all solid tumour specimens, a more 
accurate data base of cytogenetic abnormalities may be 
established. However, it is obvious that no available method can 
ensure success in each instance, and the results depend above all 
on the intrinsic characteristics of the tumour samples, i.e., the 
number of viable cells, the size of the necrotic areas and 
fibrous stroma, and the in vitro growth and differentiation rate 
of the tumour cells in a given culture system. Furthermore, it 
must be kept in mind that each technique introduces bias with 
respect to tumour cell diversity. 
It should also be mentioned that the success rate of 
cytogenetic analysis of gynaecologic solid tumours would vary 
greatly with the type of tumour. The final results , banded 
chromosomes of high quality, are directly related to the ability 
to culture In vitro the tumour cells and to the ability of the 
cytogeneticist in tailoring the various procedures to the type of 
tumour being examined. 
Chromosomal changes in gynaecologic malignancy 
The main objective of this project is to search for 
characteristic chromosomal changes that are specific for 
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particular types of tumour. It is hoped to contribute to this aim 
by reporting the 20 cases of gynaecologic solid malignancy and 
an ovarian carcinoma cell line studied with chromosome banding 
techniques. 
The data in this study support previously reported common 
aberrations of chromosome 1 in cervical cancer and ovarian 
cancer, chromosome 10 in uterine corpus cancer. Additionally, 
there were other aberrations of chromosome 3, 5, 7, 9 and 17 in 
cervical cancer, chromosome 2, 3, 4 and 11 in uterine corpus 
cancer and chromosome 8, 11 and 13 in ovarian cancer. However 
cancer is a multistep process and its progression is a complex 
secondary phenomenon that may involve a multitude of genes 
located in different chromosomes (Satya-Prakash et al,, 1981). 
Cytogenetically, similar nonrandom changes are present in tumours 
of different origins, whereas a distinct cytogenetic pattern can 
be found in various tumours with an identical histology. Such 
data stress the functional and structural heterogeneity of these 
chromosomal alterations and are indicative of the variety of 
mechanisms through which they influence the neoplastic clonal 
expansion. The fact that chromosome 1 is reported to be affected 
in a variety of tumours suggests that chromosome 1 changes may 
play a role in the evolution of all types of malignancy (Atkin, 
1986) by conferring the tumour with a proliferative advantage, 
aiding in the maintenance of the tumour, or contributing to its 
resistance to therapy. The finding of high incidence of 
I 
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chromosome 1 aberration in the present study on cervical cancer 
further support this assumption. 
Further research 
The ultimate goal of the molecular and chromosomal study of 
cancer cells is the identification of the genes involved in 
neoplastic transformation. A large number of oncogenes have now 
been characterized (Verma, 1986; Nishimura and Sekiya, 1987), and 
it has been noted that oncogene locations often coincide with 
一飞 chromosome breakpoints (Heim and Mitelman, 1987b), although this 
correlation is largely based on the more plentiful data on 
leukemias and lymphomas. It is interesting that many though not 
all oncogenes are located close to the telomeres of chromosomes 
(Lima-de-Faria and Mitelman, 1986). Oncogene alterations, which 
include activation and amplification as well as allelic deletions 
(Yokota et al.,1986), are somewhat variable in solid tumours. 
Finally, it is clear that besides protooncogenes, growth factor, 
and receptor genes, many other types of genes may be implicated 
< in carcinogenesis, such as genes coding for zinc finger proteins 
or transcription factors. This could be an explanation for the 
nonrandom and nonspecific involvement of some parts of the genome 
in many solid tumours. 
As in other field, cancer research should be carried out by 
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specialists. When it comes to pedigrees, the acquisition of 
family data, and their interpretations, the clinical geneticist 
is the specialist. The rational study of the biology of cancer is 
by no mean a field for laboratory scientists alone. 
Contributions now come not only from cy togenet ist s, 
immunologists, virologists, molecular geneticists, 
pharmacologists, medical, pediatric, surgical oncologists, 
radiotherapists, and epidemiologists, but also from specialists 
in linkage analysis and from clinical geneticists, among others. 
Other members of the medical genetics profession, such as genetic 
counselors, genetics associates, and genetics nurses are 
…increasingly needed in both research and patient care. In the 
future, the systematic cytogenetic analysis of large series of 
tumours using a standardized method in the framework of 
cooperative studies should allow researchers to assign primary 
specific changes to different subsets of neoplasms, with major 
implications for nosology, diagnosis, and prognosis (Sandberg et 
ai., 1988). Furthermore, the development of computer-assisted 
automated chromosome analysis techniques will make this 
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